CURRICULUM VITAE RAJPUT, Ali Hussain - College of Medicine ...

I. PERSONAL
September 2011
CURRICULUM VITAE
RAJPUT, Ali Hussain
Born: December 8, 1934
Married: Wife – Karla Jean
Children: Alexander
Rachel
Citizenship
Canadian
Office Address
Division of Neurology
Royal University Hospital
Room 1663, 103 Hospital Drive
Saskatoon, SK S7N 0W8
Tel: (306) 966-8009
Fax: (306) 966-8030
Home Address
3503 Balfour Street
Saskatoon, SK S7H 3Z5

II. EDUCATION & PERSONAL TRAINING
January 6, 2011 2
Dr. Ali H. Rajput
M.B.B.S. University of Sind, Pakistan, 1958, Liaquat Medical College
M.Sc. (Neurology) University of Michigan, Department of Neurology, 1966
F.R.C.P. Royal College of Physicians and Surgeons of Canada, Neurology, 1966
III. OTHER CREDENTIALS
Senior House Physician, Liaquat Medical College Hospital, Pakistan, 1958-1959
Physician, Private Practice of Family Medicine, Sanghar, West Pakistan, 1959-1960
Rotating Internship, Michael Reese Hospital, Chicago, Illinois,
July 1, 1960 - June 30, 1961
Resident, Internal Medicine, Metropolitan Hospital, New York,
July 1, 1961 - June 30, 1962
Resident, Psychiatry, Rockland State Hospital, Orangeburg, New York,
July 1, 1962 – June 30, 1963
Resident, Neurology, University Hospital, Ann Arbor, Michigan,
July 1, 1963 – June 30, 1966
Resident, Neuropathology, Kingston General Hospital, Kingston, Ontario,
July 1, 1966 – June 30, 1967
IV. APPOINTMENTS AND PROMOTIONS
Present position – Professor Emeritus (2002 – present)
Professor of Neurology (1980-2002)
Head, Division of Neurology (1985-2001) (Medicine)
Acting Head, Department of Clinical Neurological Sciences, 1986-87
Associate Professor, Tenured, 1973-1980 (Department of Medicine 1973-1976),
(Department of Clinical Neurological Sciences 1976-1980)
Assistant Professor, Tenured, 1970-1973, Department of Neurology (Medicine)
Lecturer, 1967-1968, Neurology (Department of Medicine)
V. LEAVES
Sabbatical 1980 -1981
Mayo Clinic – Rochester, MN

VI. HONOURS
Saskatchewan Physician of the Year 2006
Saskatoon Citizen of the Year 2006
Saskatchewan Centennial Medal September 2005
Communication Leadership Award, Toastmasters International June 2005
Distinguished Researcher Award. University of Saskatchewan 2002
(First Clinical Faculty member to receive this award)
Queen’s Golden Jubilee Medal 2002
January 6, 2011 3
Dr. Ali H. Rajput
Distinguished Canadian Award for Lifetime Achievement in Medicine. Presented by
University of Regina May 9, 2002
Morton Schulman Award. Presented by Parkinson Society Canada – November 2001
For excellence of care and compassion for his patients.
Doctors of Excellence Award. Presented by Dystonia Medical Research Foundation
(USA) September 2000
Invited to join their excellences, Governor General of Canada and Mrs. Diana Fowler
LeBlanc on a state visit to The Republic of India and the Islamic Republic of Pakistan.
March 22 – April 7, 1998.
Received Officer of Order of Canada Award - July, 1997.
Recipient, Fourth Annual Tony Dagnone Spirit of Royal University Hospital Award, June
1996.
Dr. S. Abo El-Ghar Research Fellow of Dr. Rajput won first prize for paper “Reactive
Oxygen Metabolites and Essential Tremor” at the 36 th Annual World Congress of the
International College of Angiology in New York, July 1994.
Saskatchewan Order of Merit, 1993.
Ciba-Geigy Award for the best original article “Accuracy of Clinical Diagnosis in
Parkinsonism – A Prospective Study”. CJNS 1991: 18:275-278
1991 Rotary Golden Wheel Award for Excellence in Science & Technology

January 6, 2011 4
Dr. Ali H. Rajput
Video production “Reopening the Therapeutic Window” has won the following
prestigious awards: (1) Third place in the International Industrial Film Festival in
Chicago 1991; (2) Judged as the best video in Corporate, Video and TV Trination
European Competition in 1998; (3) Awarded the best educational video prize by the
British Medical Association in 1999; (4) Received silver medal (second prize) at the
International Film, Television, and Multimedia Biennial Festival in Life Sciences Video
Competition in 1999.
Co-author on paper “Oxygen Free Radicals in Pathogenesis of Parkinson’s Disease)
awarded first prize for post presentation at Canadian Society of Clinical Chemists,
Montreal, Quebec, June 1991
R.J. Uitti (student) won Milton Shy award for Neurology research in North America,
1988 (The only Canadian student to win this)
R.J. Uitti (student) won Canadian Society for Clinical Investigations award for research,
1986
Gold Medal for highest marks in the graduating class of Medicine, 1958, University of
Sind
Award for highest marks in Internal Medicine in the Class of 1958, University of Sind
Award for highest marks in Obstetrics and Gynecology in the Class of 1958, University
of Sind
VIII. PREVIOUS POSITIONS RELEVANT TO U. OF S.
Nil
IX. TEACHING RECORD
Use of BOTOX in dystonia training (1/2 day) Dr. M. Fink, Saskatoon, SK, Dec 13/93
Use of BOTOX in dystonia training (1/2 day) Dr. L. Rudychyk, Saskatoon, SK Nov 29/93
Use of BOTOX in dystonia training (1/2 day) Dr. F. Veloso, Saskatoon, SK Aug 16/93
Supervisor, M. Prasad, Pharmacy Student. 1993
Supervisor, Sylvia Bauer, Elective Student (Germany)
Jeff Johnson, MSc. Clinical Pharmacy June 1991
Extended refresher course supervisor – Dr. J. Lal 1990-91
Advisor to BSc (Medicine) Dean Wingerchuk, 1990. Investigation of the effect of
Deprenyl on an animal model in Parkinson’s disease.
External examiner for MSc. Pathology student, Cynthia Balion, May 28/90

January 6, 2011 5
Dr. Ali H. Rajput
Department of Medicine, Resident Research Adjudicator
Summer students, one student almost every year (notable ones: Ryan Uitti and
Brian Thiessen)
Neurosciences JURSI Coordinator 1985-present
JURSI Oral examinations on 2 JURSI alternate week
Neurology Residency Program Director 1985-1990
Chairman, Neurology Systems 1972-1980
X. THESES SUPERVISED
Member, Supervisory Committee. Karen Barber, Physiotherapy
External examiner for M.Sc. thesis of Dr. Lalita Bharadwaj for Dept of Pathology,
Feb 17, 1993
External examiner for M.Sc. thesis of Dr. Liyan Liu for Dept. of Community Health
& Epidemiology, Feb 3, 1993.
Student examiner, H. Thiel, MSc. Thesis (Aug 15/91) “The Effect of Various Head
and Neck Positions on Vertebral Artery Blood Flow – A Study Using Doppler
Ultrasound”,
1991
L. Klassen, MSc. Physiotherapy, “The Reliability and Validity of Three Methods Used to
Quantify Spasticity”, 1987
XI. BOOKS, CHAPTERS IN BOOKS, EXPOSITORY AND REVIEW ARTICLES
Published:
A Rajput , AH Rajput. Chapter 10. Three faces of essential tremor. In: S Reich (ed.),
Movement Disorders: 100 Instructive Cases, pp.39-41. Informa healthcare, 2008.
ISBN-10: 1 84184 524 8.
ML Rajput, A Rajput, AH Rajput. Chapter 5. Epidemiology of Parkinson’s Disease. In:
SA Factor, WJ Weiner (eds.), Parkinson’s Disease, Diagnosis and Clinical Management
– Second Edition, pp.39-44. Demos Medical Publishing, 2008. ISBN-10: 1-933864-00-
1
ML Rajput, A Rajput, AH Rajput. Chapter 2. Epidemiology. In: R Pahwa, KE Lyons
(eds.), Handbook of Parkinson’s Disease - Fourth Edition, pp.19-27. Informa
Healthcare USA, Inc., 2007. ISBN-10: 0-8493-7621-1
A Rajput, AH Rajput. Chapter 53. Old Age and Parkinson’s Disease. In: WC Koller, E
Melamed (eds.), Handbook of Clinical Neurology, Vol. 84 (3 rd series) Parkinson’s

January 6, 2011 6
Dr. Ali H. Rajput
disease and related disorders, Part II, pp.427-444. Elsevier, 2007. ISBN 978 0 444
52893 3.
A Rajput, AH Rajput. Chapter 5. Neuropathology and Neurochemistry of Essential
Tremor. In: KE Lyons, R Pahwa (eds.), Handbook of Essential Tremor and other
Tremor Disorders, pp.67-76. Taylor & Francis Group, 2005. ISBN-10: 0-8247-2645-6.
Robinson Christopher A. and Rajput Ali H. The Neuropathology of Parkinson’s Disease
and Other Parkinsonian Disorders. Book: Parkinson’s Disease; Edited By Ebadi M. and
Pfeiffer R.F.; CRC Press; Boca Raton, Florida; 2005 pp401-418.
Alexander H. Rajput and Ali H. Rajput. Section 16.2 Gait and movement disorders. In:
R Jones, N Britten, L Culpepper, DA Gass, R Grol, D Mant, C Silagy (eds.), Oxford
Textbook of Primary Medical Care Volume 2: Clinical Management, pp.1239-1242.
Oxford University Press, 2004.
AH Rajput, A Rajput. Chapter 51. Movement Disorders and Aging. In: RL Watts, WC
Koller (eds.), Movement Disorders, 2 nd Edition, pp. 837-853. McGraw-Hill, 2004. ISBN:
0-07-137496-5.
AH Rajput, A Rajput, M Rajput. Chapter 2. Epidemiology of Parkinsonism. In: R
Pawha, KE Lyons, WC Koller (eds.), Handbook of Parkinson’s Disease - Third Edition,
pp.17-42. Marcel Dekker, Inc., 2003. ISBN: 0-8247-4242-7.
Rajput, AH. Levodopa Does Not Enhance Nigral Degeneration. Book Chapter in
Mapping the Progress of Alzheimer’s and Parkinson’s Disease. Published by Kluwer
Academic/Plenum Publishers. New York. 2001 pp337-341
Rajput ML, Rajput AH. Epidemiology of Parkinsonism. Book Chapter. Chapter 5,
Parkinson’s Disease, Diagnosis and Clinical Management. Edited by: Stewart A Factor,
William J. Weiner, Published by Demos, New York 2002 pp31-40
Rajput AH. The Protective Role of Levodopa in the Human Substantia Nigra. Book
Chapter. Chapter 33, Parkinson’s Disease: Advances in Neurology Vol. 86, Edited by
Donald Calne and Susan Calne, Published by Lippincott Williams & Wilkins 2001 p327-
336
Rajput AH. Parkinson’s Disease and Related Disorders. Chapter 96, Principles of
Geriatric Medicine and Gerontology, Fourth Edition. Edited by W.R. Hazzard, J.P.
Blass, W.H. Ettinger, J.B. Halter, J.G. Ouslander, Published by McGraw-Hill 1999
Rajput AH. Movement Disorders and Aging. Movement Disorders: Neurologic Principles
and Practice. Edited by: R. Watts, W. Koller, Published by McGraw Hill.
Chapter 50:1996:673-686

January 6, 2011 7
Dr. Ali H. Rajput
Rajput AH. Pathological and Neurochemical Basis of Essential Tremor. Handbook of
Tremor Disorders, Eds. Koller & Findley. Pub. Marcel Dekker Inc., New York, 1994
pp233-244.
Rajput AH. Clinical Features of Tremor in Extrapyramidal Syndromes. Handbook of
Tremor Disorders . Ed.: Koller & Findley. Pub. Marcel Dekker Inc., New York, 1994
pp275-291
Rajput AH. Neurodegenerative Diseases. Parkinson’s Disease. Clinical Features and
Natural History of Parkinson’s disease (Special Consideration of Aging) Pub. W.B.
Saunders, Ed: Donald B. Calne. 1993;33:555-571
Rajput AH. Parkinsonism Aging and Gait Apraxia. Parkinsonian Syndromes. Pub: Pub.
Marcel Dekker Inc., New York, Eds: M.B. Stern & W.C. Koller, 1993;32:511-532
Rajput AH. Current Concepts in the Etiology of Parkinson’s Disease. Book Chapter in
Current Concepts in Parkinson’s Disease Research. Eds: J.S. Schneider and M.
Gupta. Pub: Hogrefe & Huber, 1993 pp11-19
Rajput AH. Prevalence of Dementia in Parkinson’s Disease. Book chapter in
Parkinson’s Disease. Neurobehavioral Aspects. Oxford University Press, Eds. S.J.
Huber and J.L. Cummings, 1992 pp119-131
Parkinson Study Group (A.H. Rajput). Effect of selegiline (L-Deprenyl) on the
progression of disability in early Parkinson’s Disease: a preliminary report.
Neuroprotective therapy in Early Parkinson’s Disease. Eds: U.K. Rinne, E. Heinonen.
Pub: Orion Corp, Farmos, Turku, Finland, 1991 pp25-32
Hornykiewicz O, Kish SJ, Rajput AH. Neurochemical Aspects of Parkinson’s Disease
and the Dementing Brain Disorders: Relation to Brain Aging. In Basis Clinical and
Therapeutic Aspects of Alzheimer’s and Parkinson’s Diseases. Eds: T. Nagatsu et al.
Plenum Pub., New York, 1990
Thiessen B, Rajput AH, Laverty W, Desai H. Age, Environments and the Number of
Substantia Nigra Neurons. Advances in Neurology, Parkinson’s disease: Anatomy,
Pathology & Therapy. Eds. M.B. Streifler, A.D. Korczyn, E. Melamed, M.B.H. Youdim,
Raven Press, New York, Vol 53, 1990
Shoulson I., (A.H. Rajput – Parkinson Study Group). Protective Therapy for Parkinson’s
Disease, in Therapy of Parkinson’s Disease. W.C. Koller, G. Paulson (Eds), Marcel
Dekker, N.Y. 1990 pp357-358
Shoulson I., (A.H. Rajput – Parkinson Study Group). Experimental Therapeutics
Directed at the Pathogenesis of Parkinson’s Disease. Handbook of Experimental
Pharmacology: Drugs for Treatment of Parkinson’s Disease, D.B. Calne (Ed, Springer-
Verlag, Berlin, 1989 pp289-305

Rajput AH. Diagnosis and Initial Treatment of Parkinson’s Disease. THE
PARKINSONIST. Pub. The Medicine Group Vol. 2, no. 1, 1989 pp1-4
January 6, 2011 8
Dr. Ali H. Rajput
Heffernan L, Rajput AH, Suchowersky O. (Monograph) Congress of the International
Medical Society of Motor Disturbances, Congress Report, Ed. R.M. Slack, 1988
Rajput AH, Uitti RJ, Stern W, Laverty W. Early Onset Parkinson’s Disease and
Childhood Environments. Advances in Neurology (Vol 45) Eds. M.B. Yhar & K.J.
Bergmann. Raven Press, New York, 1986 pp295-297
Kish S, Rajput A, Gilbert J, Rozdilsky B, Chang L, Shanak K, Hornykiewicz O. GABAdopamine
Relationship in Parkinson’s Disease Striatum. Advances in Neurology. Vol
45, Eds. M. Yahr & K. Bergman, Raven Press, New York, 1986 pp75-77
Rajput AH, Offord K, Beard CM, Kurland LT. Epidemiological Survey of Dementia in
Parkinsonism and Control Population. Advances in Neurology, 40, Chapt. 27, 1983
pp229-234
Lucas AR, Beard CM, Rajput AH, Kurland LT. Gilles de la Tourette Syndrome. Raven
Press, New York, Advances in Neurology, 35, 1982 pp267-269
XII. PAPERS IN REFERRED JOURNALS – PUBLISHED/ACCEPTED
Published:
Paris-Robidas S, Brochu E, Sintes M, Emond V, Bousquet M, Vandal M, Pilote M,
Tremblay C, Di Paolo T, Rajput AH, Rajput A, Calon F. Defective dentate nucleus
GABA receptors in essential tremor. Brain (In Press) Sept 2011
Rajput AH, Rajput A. Significance of cerebellar Purkinje cell loss to pathogenesis of
essential tremor. Parkinsonism and Related Disorders 2011;17:410-412.
Rajput AH, Robinson CA, Rajput ML, Rajput A. Cerebellar purkinje cell loss is not
pathognomonic of essential tremor. Parkinsonism and Related Disorders 2011;17:16-
21.
Rajput AH, Uitti RJ, Rajput A, Offord KP. Mortality in Parkinson’s disease. Movement
Disorders 2010; 25: 507-508.
Vilariño-Güell C, Wider C, Aasly JO, White LR, Rajput A, Rajput AH, Lynch T,
Krygowska-Wajs A, Jasinska-Myga B, Opala G, Barcikowska M, Czyzewski K, Wu RM,
Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Association of pyridoxal kinase and
Parkinson disease. Annals of Neurology 2010; 67: 409-11.

January 6, 2011 9
Dr. Ali H. Rajput
Hopp, K., Popescu, B. F., McCrea R. P., Harder, S.L., Robinson, C.A., Haacke, M.E.,
Rajput, A.H., Rajput, A., Nichol, H. Brain iron detected by SWI high pass filtered phase
calibrated with synchrotron x-ray fluorescence. Journal of Magnetic Resonance
Imaging 2010; Volume 31(6):1346-1354.
Tong, J., Wong, H., Guttman, M., Ang, L.C., Forno, L.S., Shimadzu, M., Rajput, A.H.,
Muenter, M.D., Kish, S.J., Hornykiewicz, O., Furukawa, Y. Brain alpha-synuclein
accumulationi in multiple system atrophy, Parkinson’s disease and progressive
supranuclear palsy: a comparative investigation. Brain (2010); 133(Pt1):172-188.
Rajput A, Vilariño-Güell C, Rajput ML, Ross OA, Soto-Ortolaza AI, Lincoln SJ, Cobb
SA, Heckman MG, Farrer MJ, Rajput AH. Alpha-synuclein polymorphisms are
associated with Parkinson disease in a Saskatchewan population. Movement Disorders
2009; 24: 2411-2414.
Ouattara, B., Gregoire, L., Morissette, M., Gasparini, F., Vranesic I., Bilbe, G., Johns,
D.R., Rajput, A., Hornykiewicz, O., Rajput, A.H., Gomez-Mancilla, B., Di Paolo, T.
Metabotropic glutamate receptor type 5 in Levodopa-induced motor complications.
Neurobiological Aging: Dec., 2009.
Cobb, S.A., Wider, C., Ross, O.A., Mata, I.F., Adler, C.H., Rajput, A., Rajput, A.H., Wu,
R.M., Hauser, R., Josephs, K.A., Carr, J., Gwinn, K., Heckman, M.G., Aasley, J.O.,
Lynch, T., Uitti, R.J., Wszolek, Z.K., Kapatos, G., Farrer, M.J. GCH1 in early-onset
Parkinson’s disease. Movement Disorders 2009; 24(14):2070 – 2075.
Rajput, A.H., Voll, A., Rajput, M.L., Robinson, C.A., Rajput, A. Course in Parkinson
disease sybtypes: A 39-year clinicopathologic study. Neurology; 2009; 21; 73(3):206-
212.
Wider, C., Lincoln, S. Dachsel, J.C., Kapatos, G., Heckman, M.G., Diehl, N. N.,
Papapetropoulos, S., Mash, D., Rajput, A., Rajput, A.H., Dickson, D.W., Wszolek, Z.K.,
Farrer, M.J. GCHI expression in human cerebellum from healthy individuals is not
gender dependent. Neuroscience Lett. 2009; 462(1): 73-75.
Samadi, P., Rajput, A., Calon, F., Gregoire, L., Hornykiewicz, O., Rajput, A.H., Di Paolo,
T. Metabotropic glutamate receptor II in the brains of Parkinsonian patients. J.
Neruopathol Exp. Neurology; 68(4):374-382.
Allen, A.L., Luo, C., Montgomery, D.L., Rajput, A.H., Robinson, C.A., Rajput, A.
Vascular pathology in male Lewis rats following short-term, low-dose rotenone
administration. Vet Pathol. 2009; 46(4): 776-782.
Popescu, B.F., Robinson, C.A., Rajput, A., Rajput, A.H., Harder, S.L., Nighol, H. Iron,
copper, and zinc distribution of the cerebellum. Cerebellum; 2009; 8(2): 74-79.

January 6, 2011 10
Dr. Ali H. Rajput
Wider, C., Dachsel, J.C., Soto, A.L., Heckman, M.G., Diehl, N.N., Yue, M., Lincoln, S.,
Aasly, J. O., Haugarvoll, K., Trojanowski, J.Q., Papapetropoulos, S., Mash, D., Rajput,
A., Rajput, A.H., Gibson, J.M., Lynch, T., Dickson, D.W., Uitti, R.J., Wszolek, Z.K.,
Farrer, M.J., Ross, O.A. FGF20 and Parkinson’s disease: no evidence of association of
pathogenicity via alpha-synuclein expression. Movement Disorders 2009; 24(3) 455-
459.
Rajput, A.H., Maxood, K., Rajput, A. Classic essential tremor changes following
cerebellar hemorrhage. Neurology; 2008 71(21):1739-1740.
Rajput, Ali, H., Robinson, Christopher, A., Rajput, Alexander H. Benign Tremulous
Parkinsonism: A Clinicopathological Study. Journal: Movement Disorders(2008), Vol.
23, NO 2; 311 - 312
Postuma, Ronald B., Wolfson, Christina, Rajput, Ali, Stoessl, A. Jon, Martin, W.R.,
Wayne, Schowersky, Oksana, Chouinard, Sylvain, Panisset, Michel, Jog, Mandar S.,
Grimes, David Al., Marras, Connie, Lang, Anthony E. Is There Seasonal Variation in
Risk of Parkinson’s Disease? Journal: Movement Disorders(2007); Vol. 22 NO. 8, 1097
- 1101
Louis, Elan D., Faust, Phyllis L., Vonsattel, Jean-Paul G., Honig, Lawrence S., Rajput,
Alex, Robinson, Christopher A., Rajput, Ali, Pahwa, Rajesh, Lyons, Kelly E., Ross, G.
Webster, Borden, Sarah, Moskowitz, Carol B., Lawton, Arlene, Hernandez, Nora.
Neuropathological changes in essential tremor: 33 cases compared with 21 controls.
Journal: Brain (2007), 130, 3297 - 3307
Rajput Ali H., Hauser, Robert A., Lew, Mark F., Hurtig, Howard I., Ondo, William G.,
Wojcieszek, Joanne, Fitzer-Attas, Cheryl J. Long-term Outcome of Early Versus
Delayed Rasagiline Treatment in Early Parkinson’s Disease. Movement Disorders 2009;
Vol. 24. No. 4; 564-573
Rajput Ali H., Rajput Alexander H., Nichols, W.C., Kissell, D.K., Pankratz, N., Pauciulo,
M. W., Elsaesser, V.E., Clark, K.A., Halter, C.A., Rudolph A., Wojcieszek, J., Pfeiffer,
R.F., Foroud, T. Variation in GIGYF2 is not associated with Parkinson disease.
Neurology 2009; 72:1886-1892
Rajput,A.H., Sitte,H., Rajput,A., Fenton,M.E., Pifl,C., Hornykiewicz,O. Globus pallidus
Dopamine and Parkinson motor subtypes: Clinical and brain biochemical correlation.
Neurology 2008; 70: 1403-1410
Luo Can, Rajput Ali H., Akhtar Shakeel, Rajput Alexander. �-synuclein and tyrosine
hydroxylase expression in acute rotenone toxicity. International Journal Of Molecular
Medicine 2007;19:517-521

January 6, 2011 11
Dr. Ali H. Rajput
Watts R L., Jankovic J., Waters C., Rajput A., Boroojerdi B., Rao J. Randomized, blind,
controlled trial of transdermal Rotigotine in early Parkinson disease. Neurology
2007;68:272-276
Pankratz Nathan, Pauciulo Michael W., Elsaesser Veronika E., Marek Diane K., Halter
Cheryl A., Rudolph Alice, Shults Clifford W., Foroud Tatiana, Nichols William C., Rajput
A H., Rajput A., the Parkinson Study Group-PROGENI Investigators. Mutations in
LRRK2 Other than G2019S Are Rare in a North American-Based Sample of Familial
Parkinson’s Disease. Movement Disorders 2006;21(No.12):2257-2260
Parkinson Study Group (Ali Rajput). A Randomized Controlled Trial of Etilevodopa in
Parkinson’s Disease Patients with Motor Fluctuations. Archives of Neurology
2006;63:210-216
Rajput A., Dickson D W., Robinson C A., Ross O A., Dächsel J C., Lincoln S J., Cobb S
A., Rajput M L., Farrer M J. Parkinsonism, Lrrk2 G2019S, and tau neuropathy.
Neurology 2006;67(8):1506-1508
Weiner William J., Rajput Ali. Conflicts of interest in expert witnesses – Is there a
solution? Neurology 2006;67:2113-2114
Rajput Alexander H and Rajput Ali. Increased tremor severity in bilineal essential
tremor: A report of two families. Parkinsonism and Related Disorders 2006;12:323-326
Biglan Kevin, Schwid Steven, Eberly Shirley, Blindauer Karen, Fahn Stanley, Goren
Tamar, Kieburtz Karl, Oakes David, Plumb Sandra, Siderowf Andrew, Stern Matthew,
Shoulson Ira, and the Parkinson Study Group. Rasagiline Improves Quality of Life in
Patients With Early Parkinson’s Disease; Movement Disorders 2006; 21(No.5):616-623
Goetz C.G., Schwid S.R., Eberly, S.W., Oakes D., Shoulson I., and the Parkinson Study
Group TEMPO and PRESTO Investigators. Safety of Rasagiline in elderly patients with
Parkinson disease. Neurology 2006;66:1427-1429.
Pankratz Nathan, Byder Lisa, Halter Cheryl, Rudolph Alice, Shults Clifford W. Conneally
P. Michael, Foroud Tatiana, Nichols William C. and the Parkinson Study Group-
PROGENI Investigators. Presence of an APOE4 Allele Results in Significantly Earlier
Onset of Parkinson’s Disease and a Higher Risk With Dementia. Movement Disorders
2006; 21(No.1):45-49
Rajput Alex and Rajput Ali H. Parkinson’s disease management strategies. Expert
Rev. Neurotherapeutics 2006; 6(No.1):91-99.
Nataraj Andrew, Rajput Ali H. Parkinson’s Disease, Stroke, and Related Epidemiology.
Movement Disorders 2005;20(No.11):1476-1480.

January 6, 2011 12
Dr. Ali H. Rajput
Marras C, McDermott M.P., Rochon P.A.,Tanner C.M., Naglie G.,Rudolph A., Lang
A.E., and the Parkinson Study Group (A.H. Rajput). Survival in Parkinson disease:
Thirteen-year follow-up of the DATATOP cohort. Neurology 2005;64:87-93.
Camicioli Richard, Rajput Ali, Rajput Michelle, Reece Christian, Payami Haydeh, Hao
Chunhai, and Rajput Alex. Apolipoprotein E �4 and catechol-o-methyltransferase
alleles in autopsy-proven Parkinson’s Disease: Relationship to dementia and
hallucinations. Movement Disorders 2005;20 (No.8):989-994
Nataraj Andrew and Rajput Ali H. Parkinson’s Disease, Stroke, and Related
Epidemiology. Movement Disorders 2005;20 (No.11):1476-1480.
Toth Cory, Rajput Michelle and Rajput Ali H. Anomalies of Asymmetry of Clinical Signs
in Parkinsonism. Movement Disorders 2004;19 (No.2):151-157.
Rajput Alex, Robinson CA, Rajput AH. (Reply from the authors) Essential tremor
course and disability: A clinicopathologic study of 20 cases. Neurology 2004;63(No.8):
1541-1542.
Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonucelli U, Damier P, De Yebenes J,
Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P,
Katzenschlager R, Langston WJ, LeWitt P, Melamed E, Mena MA, Michel PP,
Mytilineou C, Obeso JA, Poewe W, Quinn N, Raisman-Vozari R, Rajput AH, Rascol O,
Sampaio C, Stocchi F. Levodopa in the Treatment of Parkinson’s Disease: Current
Controversies. Movement Disorder 2004;19(No.9):997-1005.
Rajput AH, Fenton ME, Di Paolo T, Sitte H, Pifl C, Hornykiewicz O. Human brain
dopamine metabolism in levodopa-induced dyskinesia and wearing off. Parkinsonism
and Related Disorders 2004;10:221-226.
Calon F, Dridi M, Hornykiewicz O, Bedard PJ, Rajput AH, Di Paolo T. Increased
adenosine A2A receptors in the brain of Parkinson’s disease patients with dyskinesias.
Brain 2004;127:1075-1084.
Nichols WC, Uniacke SK, Pankratz N, Reed T, Simon DK, Halter C, Rudolph A, Shults
CW, Conneally PM, Foroud T, Parkinson Study Group (Rajput AH). Evaluation of the
role of Nurr1 in a large sample of familial Parkinson’s disease. Movement Disorders
2004;19 (No.6):649-55.
Pankratz N, Uniacke SK, Halter CA, Rudolph A, Shults CW, Conneally PM, Foroud T,
Nichols WC and the Parkinson Study Group (Rajput AH). Genes influencing Parkinson
disease onset. Replilcation of PARK3 and identification of novel loci. Neurology
2004;62:1616-1618.
Rajput Alex, Robinson CA, Rajput AH. Essential tremor course and disability: A
clinicopathological study of 20 cases. Neurology 2004;62:932-936.

January 6, 2011 13
Dr. Ali H. Rajput
Parkinson Study Group (Rajput AH). A Controlled, Randomized, Delayed-Start Study of
Rasagiline in Early Parkinson Disease. Arch Neurol 2004;61:561-566.
Fitzmaurice Paul S., Ang Lee, Guttman Mark, Rajput Ali H.; Furukawa Yoshiaki, Kish
Stephen J. Nigral Glutathione Deficiency Is Not Specific for Idiopathic Parkinson’s
Disease. Movement Disorders 2003;18 (No.9):969-976.
Calon F, Rajput AH, Hornykiewicz O, Bedard PJ, Di Paolo T. Levodopa-induced motor
complications are associated with alterations of glutamate receptors in Parkinson’s
disease. Neurobiol Dis 2003;14(No.3):404-416.
Calon F, Morissette M, Rajput AH, Hornykiewicz O, Bedard PJ, Di Paolo T. Changes of
GABA Receptors and Dopamine Turnover in the Postmortem Brains of Parkinsonians
with Levodopa-Induced Motor Complications. Movement Disorders 2003;18:241-253.
Pankratz N, Nichols WC, Uniacke SK, Halter, Murrell J, Rudolph A, Shults CW,
Conneally PM, Foroud T, Parkinson Study Group (Rajput AH). Genome-wide linkage
analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex
Parkinson disease families. Hum Mol Genet. 2003;12(No.20):2599-608.
Pankratz N, Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults C, Conneally PM,
Foroud T, and the Parkinson Study Group (Rajput AH). Significant Linkage of
Parkinson Disease to Chromosome 2q36-37. Am.J.Hum.Genet. 2003;72:1053-1057.
Reider CR and Parkinson Study Group (Rajput AH). Reliability of Reported Age at
Onset for Parkinson’s Disease. Movement Disorders 2003;18(No.3):275-279.
Foroud T and Parkinson Study Group (Rajput AH). Heterozygosity for a mutation in the
parkin gene leads to later onset Parkinson disease. Neurology 2003;60:796-801.
Shoulson Ira, Oakes David, Fahn Stanley, Lang Anthony, Langston J. William, DeWitt
Peter, Olanow C. Warren, Penney John B., Tanner Caroline, Kieburtz Karl, Rudolph
Alice and the Parkinson Study Group. Impact of Sustained Deprenyl (Selegiline) in
Levodopa-Treated Parkinson’s Disease: A Randomized Placebo-Controlled Extension
of the Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism Trial. Ann
Neurol 2002;51:604-612
Parkinson Study Group. A Controlled Trial of Rasagiline in Early Parkinson Disease.
Arch Neurol. 2002;59:1937-1943
Rajput Ali H. Contributions of human brain biochemical studies to movement disorders.
Parkinsonism and Related Disorders 2002;8:425-431
Calon F, Birdi S, Rajput AH, Hornykiewicz O, Bedard PJ, Di Paolo T. Increase of
Preproenkephalin mRNA levels in the Putamen of Parkinson Disease Patients with

January 6, 2011 14
Dr. Ali H. Rajput
Levodopa-Induced Dyskinesias. Journal of Neuropathology and Experimental
Neurology 2002;61:186-196.
Furukawa Y and Rajput AH. Inherited myoclonus-dystonia – how many causative
genes and clinical phenotypes? Neurology 2002;59:1130-1131.
Pankratz N, Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults, Conneally PM,
Foroud T, Rajput AH and the Parkinson Study Group. Genome screen to identify
susceptibility genes for Parkinson Disease in a sample without parkin mutations.
American Journal of Human Genetics 2002;71:124-135.
Nichols WC, Pankratz N, Uniacke SK, Pauciulo MW, Halter C, Rudolph A, Conneally
PM, Foroud T, Rajput AH and the Parkinson Study Group. Linkage stratification and
mutation analysis at the parkin locus identifies mutation positive, Parkinson disease
families. Journal of Medical Genetics 2002;39:489-492.
Fitzmaurice PS, Bamsey CL, Ang L, Guttman M, Rajput AH, Furukawa Y, Kish SJ.
Brain aconitase activity is not decreased in progressive supranuclear palsy. Neurology
2002;59:137-138.
Furukawa Y, Vigouroux S, Wong H, Guttman M, Rajput AH, Ang L, Briand M, Kish SJ,
Briand Y. Brain Proteasomal Function in Sporadic Parkinson’s disease and Related
Disorders. Ann Neurol 2002;51:779-782.
Rajput AH and Rajput Alex. Parkinsonian Dementia: Diagnosis, Differentiation and
Principles of Treatment. Geriatrics & Aging 2002;5(No.4).
Birdi S, Rajput AH, Fenton M, Donat JR, Rozdilsky B, Ronbinson C, Macaulay R,
George D. Progressive supranuclear palsy diagnosis and confounding features – report
of 16 autopsied cases. Movement Disorders 2002;17(No.6):1255-1264.
Iqbal S, Baziany A, Hussain M, James S, Wright S, Hemmings S, Shuaib A, Rajput AH.
Trimetazidine as a potential neuroprotectant in transient global ischemia in gerbils: a
behavioural and histological study. Brain Res 2002;928(No.1-2):1-7.
The Global Parkinson’s Disease Survey (GPDS) Steering Committee (Rajput, AH).
Factors impacting on Quality of Life in Parkinson’s Disease: Results From an
International Survey. Movement Disorders 2002;17 (No.1):60-67.
Lyden, P, Shuaib A, Ng K, Levin K, Atkinson, RP, Rajput A, Wechsler L, Ashwood T,
Claesson L, Odergren T, Salazar-Grueso E. Clomethiazole Acute Stroke Study in
Ischemic Stroke (CLASS I). Final Results. Stroke 2002;33:122-129.
Pankratz N, Koller, DL, Foroud T, Parkinson Study Group (Rajput AH). Power to
reconstruct the genotype of a missing individual. American Journal of Human Genetics
67(No.4)(Suppl;2):332.

January 6, 2011 15
Dr. Ali H. Rajput
Rajput AH, Fenton ME, Birdi S, Macaulay R, George D, Rozdilsky B, Ang LC,
Senthilselvan A, Hornykiewicz O. A Clinical-Pathological Study of Levodopa
Complications. Movement Disorders 2002;17(No.2):289-296.
Tckumala PK, Calon F, Rahman Z, Birdi S, Rajput AH, Hornykiewicz O, Di Paolo T,
Bedard PJ, Nestler EJ. Elevated Levels of FosB and RGS9 in Striatum in Parkinson’s
Disease. Biological Psychiatry 2001;50:813-816.
Rajput A., Rajput AH. Progressive Supranuclear Palsy. Clinical Features,
Pathophysiology and Management. Drugs Aging 2001:18(No.12):913-925.
Winblad B., Engedal K., Soininen H., Verhey F., Waldemar G., Wimo A., Wetterholm A.-
L., Zhang R., Haglund A., Subbiah P. and the Donepezil Nordic Study Group. A 1-year,
randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.
Neurology 2001;57:489-495.
Sacco RL, DeRosa JT, Haley EC, Levin B, Ordronneau P, Phillips SJ, Rundek T,
Snipes RG, Thompson JLP, for the GAIN Americas Investigators (Rajput AH). Glycine
Antagonist in Neuroprotection for Patients With Acute Stroke. GAIN Americas: A
Randomized Controlled Trial. JAMA 2001;285(No.13):1719-1728.
Reider CR, Hlater CA, Foroud T, Oakes D, and the Parkinson Study Group (Rajput AH).
Reliability of Self-Reporting Age of Onset for Parkinson’s Disease. Movement
Disorders 2001;16(No.5):991.
Tekumalla PK, Calon F, Rahman Z, Birdi S, Rajput AH, Hornykiewicz O, Di Paolo T,
Bedard PJ, Nestler EJ. Elevated Levels of FosB and RGS9 in Striatum in Parkinson’s
Disease. Biol Psychiatry 2001;50:813-816.
Rajput AH, Uitti R, et al. Levodopa prolongs life expectancy and is non-toxic to
substantia nigra. Parkinsonism and Related Disorders 2001;8:95-100.
Deng Y, Rajput AH, Miyashita H, Rajput A, Birdi, S, Hornykiewicz O. Increased
Concentration of a Novel Compound, 1-Acetyl-6,7-Dihydroxy-1,2,3,4-
Tetrahydroisoquinoline, in Parkinsonian Brain. (Abstract). Journal of Proceedings of
126 th Annual Meeting of the American Neurological Association 2001;34.
Feldman H., Gauthier S., Hecker J., Vellas B., Subbiah P., Whalen E., and the
Donepezil MSAD Study Investigators Group. (Rajput,AH). A 24-week, randomized,
double-blind study of donepezil in moderate to severe Alzheimer’s disease. Neurology
2001;57:613-620.
Rajput AH, Hornykiewicz O, Deng Y, Birdi S, Miyashita H, Macaulay R. Increased
Noradrenaline Levels in Essential Tremor Brain. Neurology 2001;56(Supp.3):A302.
Rajput AH. Environmental toxins accelerate Parkinson’s Disease onset. Neurology
2001;56:4-5 (Editorial).

January 6, 2011 16
Dr. Ali H. Rajput
Brin MF, Lyons KE, Doucette J, Adler CH, Caviness JN, Comella CL, Dubinsky RM,
Friedman JH, Manyam BV, Matsumoto JY, Pullman SL, Rajput AH, Sethi KD, Tanner C,
Koller WC. A randomized, double masked, controlled trial of Botulinum toxin type A in
essential hand tremor. Neurology 2001;56:1523-1528.
Parkinson Study Group (A.H. Rajput). Pramipexole vs Levodopa as Initial Treatment for
Parkinson’s Disease. A Randomized Controlled Study. J American Medical Association
2000;284:1931-1938.
Kakkar R, Rajala R, Rajput AH, Sharma RK. Calmodulin-dependent cyclic nucleotide
phosphodiesterase isozymes: effect of an antiparkinsonian agent deprenyl. Current
Topics in Biochemical Research 2000;2:115-126.
Agid Y, Ahlskog E, Albanese A, Calne D, Chase T. De Yebenes J, Facgor S, Fahn S,
Gershanik O, Goetz C, Koller W, Kurth M, Lang A, Lees A, Lewitt P, Marsden D,
Melamed E, Michel PP, Mizuno Y, Obeso J, Oertel W, Olanow W, Poewe W, Pollak P,
Przedzorski S, Quinn N, Raisman-Vozari R, Rajput A, Stocchi F, Tolosa E. Viewpoint –
Levodopa in the Treatment of Parkinson’s Disease: A Consensus Meeting. Movement
Disorders 1999;14(No.6):911-913.
Jankovic J, Rajput AH, McDermott P, Perl DP; for the Parkinson Study Group The
evolution of Diagnosis in Early Parkinson Disease. Arch Neurol. 2000;57:369-372.
Burbridge B, Wallace K, Rajput AH, McCulloch L. Doppler ultrasound of the leg veins
of patients with Parkinson’s Syndrome. J. Psychiatry & Neurosciences
1999;24(No.4):338-40.
Furukawa Y, Nygaard TG, Gutlich M, Rajput AH, Pifl C, DiStefano L, Chang LJ, Price K,
Shimadzu M, Hornykiewicz O, Haycock JW, Kish SJ. Striatal biopterin and tyrosine
hydroxylase protein reduction in dopa-responsive dystonia. Neurology 1999;53:1032-
1041.
Rajput A, Rajput AH. The Role of Glutamatergic Mechanisms in Levodopa-
Induced Dyskinesia in Parkinson’s Disease: Pathogenesis and Therapeutic
Implications. Focus on Parkinson’s Disease 1999;11(No.2).
Rajput AH. Letter to Editor. Pathologic and biochemical studies of juvenile
parkinsonism linked to chromosome 6q. Neurology 1999;53:1375.
Dhand, A., Birdi, S., Rajput, A.H. Frequency of respiratory disorders and bradycardia in
essential tremor – consideration of treatment. Parkinsonism & Related Disorders
1998;4:7-10.
Rajput, Ali H., Rajput, Alex H., Lang, A.E., Kumar, R., Uitti, R.J., Glavez-Jimenez, N.
New Use for an Old Drug: Amantadine Disorders 1998;13(No.5):851.

January 6, 2011 17
Dr. Ali H. Rajput
Gross, D.W., Rajput, A.H., Yeung, M. Distal hereditary upper limb muscular atrophy. J.
Neurol., Neurosurg. & Psych. 1998;64:217-220.
Parkinson Study Group (A.H. Rajput). Mortality in DATATOP: A Multicenter Trial in
Early Parkinson’s Disease. Ann Neurol 1998;43:318-325
Shoulson I and the Parkinson Study Group (A.H. Rajput). DATATOP: A Decade of
Neuroprotective Inquiry. Ann Neurol 1998;44(Suppl.1):S160-S166
Rajput AH. Dopa-responsive, non-progressive sporadic Juvenile Parkinsonism.
Movement Disorders 1997;12(No.3):453-456
Rajput, A.H., Birdi, S. Epidemiology of Parkinson’s disease. Parkinsonism & Related
disorders. 1997;3(No.4):175-186.
Rajput, A.H., Uitti, Ryan J., Rajput, Alex H., Offord, K.P. Timely levodopa (LD)
administration prolongs survival in Parkinson’s disease. Parkinsonism & Related
Disorders 1997;3(No.3):159-165.
Rajput, A.H., Martin, W., Saint-Hilaire, M.H, Dorflinger, E., Pedder, S. Tolcapone
improves motor function in parkinsonian patients with the “wearing off” phenomenon: A
double-blind, placebo-controlled, multicenter trial. Neurology 1997;49:1066-1071.
Rajput, A.H., Uitti, R.J., Fenton, M.E., George, D. Amantadine effectiveness in multiple
system atrophy and progressive supranuclear palsy. Parkinsonism & Related Disorders
1997;3(No.4):211-214.
Kakker, R., Raju, R.V.S., Rajput, A.H., Sharma, R.K. Amantadine: an antiparkinsonian
agent inhibits bovine brain 60 kDa calmodulin-dependent cyclic nucleotide
phophodiesterase isozyme. Brain Research 1997;749:290-294.
Rajput, A.H., Fenton, M.E., Birdi, S., Macaulay, R. Is Levodopa toxic to human
substantia nigra. Movement Disorders 1997;12(No.5):747-751.
Rajput, A.H., Fenton, M.E., George, D., Rajput, Alex, Wilson, W., McCulloch, L.
Concordance of common movement disorders among familial cases. Movement
Disorders 1997;12(No.5):634-638.
Rajput, A., Kishore, A., Bolton, C.F., Rajput, A.H. Dopa-responsive, nonprogressive,
juvenile parkinsonism; Report of a Case. Movement Disorders 1997;12:453-456.
Wilson, J.M., Levey, A.I., Rajput, A., Ang,L., Guttman,M., Shannak, K., Niznik, H.B.,
Hornykiewicz,O., Pifl, C., Kish, S.J. Differential changes in Neurochemical markers of
striatal dopamine nerve terminals in idiopathic Parkinson’s disease. Neurology
1996;47:718-726.

January 6, 2011 18
Dr. Ali H. Rajput
Kakkar, R., Raju, R.V.S., Rajput, A.H., Sharma, R.K. Inhibition of bovine brain
calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes by Deprenyl. Life
Sciences 1996;59(No.21):337-341.
Rajput, A.H. Early onset parkinsonism. Advances in Clinical Neurosciences 1996;6:27-
35.
(Letter) Rajput, A.H. Specificity of ethanol in essential tremor. Anals of Neurology
1996;40(No.6):950.
Rajput, A.H., McHattie, J.D. Ophthalmoplegia and leg myorhythmia in Whipple’s
disease: Report of a case. Movement Disorders 1997;12(No.1):121.
Parkinson Study group (A.H. Rajput). Effect of Lazabemide on the progression of
disability in early Parkinson’s disease. Annals of Neurology 1996;40:99-107
Uitti, R.J., Rajput, A.H., Ahlskog, J.E. et al. Amantadine treatment is an independent
predictor of improved survival in Parkinson’s Disease. Neurology 1996;46:1551-1556.
Fahn, S., Brin, M.F., Dwork, A.J., Weiner, W.J., Goetz, C.G., Rajput, A.H. What is it:
Case I, 1996: Rapidly progressive parkinsonism, incontinence, impotency and
levodopa-induced moaning in a patient with multiple myeloma. Movement Disorders
1996;11(No.3):298-310.
Parkinson Study group (A.H. Rajput). Impact of Deprenyl and Tocopherol treatment on
Parkinson’s disease in DATATOP subjects not requiring levodopa. Ann Neurol
1996;39:29-36.
Parkinson Study Group (A.H. Rajput). Impact of Deprenyl and Tocopherol treatment on
Parkinson’s disease in DATATOP subjects requiring levodopa. Ann Neurol 1996;39:37-
45.
Furukawa, Y., Shimadzu, M., Rajput, Ali H., et al. GTP-Cyclohydrolase I Gene
mutations in hereditary progressive and dopa-responsive dystonia. Ann Neurology
1996;39:609-617.
Moghal, S., Rajput, A.H., D’Arcy, C., Rajput, R. Prevalence of Movement Disorders in
the Elderly Institutionalized Residents of Saskatchewan. Neuroepidemiology
1995;14:297-300
Parkinson Study Group (A.H. Rajput). The Effect of Deprenyl and Tocopherol on
cognitive Performance in Early Untreated Parkinson’s Disease. Neurology
1994:44:1756-1759

January 6, 2011 19
Dr. Ali H. Rajput
Tennis, P., Cole, T.B., Annegers, J.J., Leestma, J.E., McNutt, M., Rajput, A.H. A Cohort
Study of the incidence of sudden unexplained death in people with seizure disorder in
Saskatchewan, Canada. Epilepsia 1995;36(No.1):29-36.
Parkinson Study Group (A.H. Rajput). Cerebrospinal Fluid Homovanillic Acid in the
DATATOP Study on Parkinson’s Disease. Arch Neur 1995;52:237-245.
Uitti, Ryan J., Rajput, A.H. Parkinson’s disease Risk Factors. Neurology 1994;44:1557.
Moghal, S., Rajput, A.H., D’Arcy, C., Rajput, R. Movement disorders in Elderly
Community Residents. Neuroepidemiology 1994,13:175-178.
Rajput, A.H., Moghal, S., Rajput, Alex. Parkinson’s Disease and Essential Tremor.
Neurology 1994; 44:778 (Letter).
Rajput, A.H., Gibb, W.R.G., Zhong X.H., Shannak, K.S., Kish, S., Chang, L.G.,
Hornykiewicz, O. Dopa Responsive Dystonia – Pathological and Biochemical
observations in a case. Annals of Neurology 1994;35:396-402. Original lead article.
Shannak, K., Rajput, A., Rozdilsky, B., Kish, S., Gilbert, J., Hornykiewicz, O.
Noradrenaline, dopamine and serotin levels and metabolism in the human
hypothalamus: Observations in Parkinson’s disease and normal subjects. Brain Res
1994;639(No.1):33-41
Mosewich, R.K., Rajput, A.H., Shuaib, A., Rozdilsky, B., Ang, L. Pulmonary Embolism:
An under-recognized yet frequent cause of death in parkinsonism. Movement Disorders
1993;9(No.3):350-352
Rajput, A.H. Early Treatment of Parkinson’s disease in Early Diagnosis and early
treatment of Parkinson’s disease – Symposium Highlight, Sept 1993, 3-4.
Jankovic, Joseph, Rajput Ali H., Golbe, Lawrence I, Goodman, J. Clay. What is it?
Case I, 1993: Parkinsonism, Dysautonomia, and Ophthalmoparesis. Movement
Disorders 1993;8(No.4):525-532.
Parkinson Study Group (A.H. Rajput). A controlled trial of lazebemide (Ro-19-6327) in
levodopa-treated Parkinson’s disease. Ann Neurol 1993;33:350-356
Rajput, A.H. Diagnosis of Parkinson’s disease. Neurology 1993;43:1629-1630 (Letter)
Rajput, A.H., Rozdilsky, B., Rajput, Alex. Alzheimer’s disease and Idiopathic
Parkinson’s Disease Coexistence. J. of Geriatric Psychiatry & Neurology
1993;6(No.3):170-176
Rajput, A.H. Accuracy of Clinical diagnosis in idiopathic Parkinson’s Disease. J. Neuro
Neurosurg & Psych. 1993;56(No.8):938-939 (Letter)

January 6, 2011 20
Dr. Ali H. Rajput
Rajput, A.H. Environmental Causation of Parkinson’s Disease. Archives of Neurology
1993;50:651-652
Rajput, A.H., Rozdilsky, B., Ang, L., Rajput, Alex. Significance of parkinsonian
manifestation in essential tremor cases. Can J. Neuro Sci 1993;20:114
Rajput, A.H., Pahwa, R., Pahwa, P., Rajput, Alex. Prognostic significance of the onset
mode in Parkinsonism. Neurology 1993;43:829-830
Parkinson Study Group (A.H. Rajput). Effect of selegiline (Deprenyl) on the progression
of disability in early Parkinson’s Disease. Acta Neurol Scand Suppl. 1993;87:36-42
Parkinson Study Group (A.H. Rajput). Effects of Tocopherol and Deprenyl on the
progression of disability in early Parkinson’s Disease. New England Journal of
Medicine 1993;328:176-183
Shoulson, I., Parkinson Study Group (A.H. Rajput). An interim report of the effect of
Selegiline (L-Deprenyl) on the progression of disability in early Parkinson’s disease.
Neurology 1992;42:2111-2117
LeWitt, P.A., et al, Parkinson Study Group (A.H. Rajput). Markers of dopamine
metabolism in Parkinson’s disease. Neurology 1992;2:2111-2117
Moghal, S., Rajput, A.H. Clinico-pathological observations in multiple system atrophy.
Movement Disorders 1992;7(No.4):338-389 (Letter)
Kish, Stephen J., Bergeron Catherine, Rajput, Ali, et al. Brain Cytochrome Oxidase in
Alzheimer’s Disease. J Neurochemistry 1992;59:776-779
Kalra, J., Rajput, A., Mantha, S.V., Chaudhary, A.K., Prasad, K. Oxygen free radical
producing activity of polymorphonuclear leukocytes in patients with Parkinson’s disease.
Molecular & Cellular Biochemistry 1992;112:181-186
Kish, S.J., Shannak, K., Rajput, A.H., Deck, J.H.N., Hornykiewicz, O. Aging produces a
specific pattern of striatal dopamine loss: implications for the etiology of idiopathic
Parkinson’s disease. J. Neurochemistry 1992;58:642-648
Kalra, J., Rajput, A.H., Mantha, S.V., Prasad, K. Serum antioxidant Enzyme activity in
Parkinson’s disease. Molecular and Cellular Biochemistry 1992;110:165-168
Rajput, A.H. Frequency and Cause of Parkinson’s Disease. Can J Neurol Sci.
1992;19:103-107 Lead article
Rajput, A.H. Managing Parkinson’s Disease. The Can J Geriatrics. 1991;7(No.1):16-17

January 6, 2011 21
Dr. Ali H. Rajput
Rajput, A.H. Rozdilsky, B., Ang, L., Rajput, Alex. Clinicopathological observations in
essential tremor. Report of 6 cases. Neurology 1991;41:1422-1424
Rajput, A.H. Rozdilsky, B., Ang, L., Rajput, A. Pathogenesis of Parkinsonian
Manifestations in Essential Tremor. Movement Disorders 1991;6:3
Parkinson Study Group (A.H. Rajput). DATATOP and Clinical Neuromythology IX.
Neurology 1991;41:771-773
Rajput, A.H. Rozdilsky, B., Rajput, Alex. Accuracy of Clinical Diagnosis in
Parkinsonism. A prospective Study. Can J. NeuroSciences 1991;18:275-278 (Lead
article) (This was judged as the best original paper in 1991 & won a prize of
$2500)
Rajput, A.H, Rozdilsky, B., Ang, L. Occurrence of Resting Tremor in Parkinson’s
Disease. Neurology 1991;41:1298-1299
Rajput, A.H, Calne, D., Lang, A.E. Summary of National Conference on Parkinson’s
Disease. Can J. Neuro Sci 1991;18:87-92
Uitti, R.J., Rajput, A.H. Headache, Third Nerve Palsy, and MS. Neurology 1991;41:331
Parkinson’s Study Group (A.H. Rajput). Deprenyl’s effect at slowing progression of
parkinsonian disability: The DATATOP Study. Acta Neurol Scand 1991;84(Suppl.136):
70-86
Rajput, A.H., Rozdilsky, B., Rajput, Alex H. Essential Leg Tremor. Neurology
1990;40:1909
Parkinson’s Study Group (A.H. Rajput). Variable Expression of Parkinson’s Disease: A
Base-line Analysis of the DATATOP Cohort. Neurology 1990;40:1529-1534
Kish, S.J., Distefano, L.M., Dozic, S., Robitaille, Y., Rajput, A.H., Deck, J.,
Hornykiewicz, O. 3H – Vesamicol Binding in Human Brain Cholinergic Deficiency
Disorders. Neuroscience Letters 1990;117:347-352
Jankovic, J., McDermott, M., Carter, J., et al (A.H. Rajput). Variable clinical expression
of Parkinson’s disease: Analysis of the DATATOP database. Neurology
1990;40(No.20):1529-1534
Desai, T.H., Rajput, A.H., Desai, H. Use and Abuse of Drugs in the Elderly. Progress in
Neuropharmacology & Biological Psychiatry 1990;14:779-784
Uitti, R.J., Tanner, C.M., Rajput, A.H., Goetz, C.G., Klawans, H.L., Thiessen, B.
Hypersexuality with Antiparkinsonian Therapy. Clin. Neuropharmacology
1990;12(No.5):375-383

January 6, 2011 22
Dr. Ali H. Rajput
Shoulson, S., Fahn, Oakes, D, et al (A.H. Rajput – Parkinson Study Group). Deprenyl
for the Treatment of Early Parkinson’s Disease. New England Journal of Medicine
1990;322:1527-1528
Rajput, A.H., Rozdilsky, B., Rajput, Alex, Ang, L. Levodopa Efficacy and Pathological
Basis of Parkinson Syndrome. Clinical Neuropharmacology 1990;13(No.6):553-558
Uitti, R.J., Rajput, A.H., Rozdilsky, B., et al. Regional Metal Concentrations in
Parkinson’s Disease, Other Chronic Neurological Disease, and Control Brains. Can J
Neuro Sci 1989;16:310-314
Rajput, A.H., Uitti, R.J., Sudhakar, S., Rozdilsky, B. Parkinsonism and Neurofibrillary
Tangle Pathology in Pigmented Nuclei. Ann Neurol 1989;25:602
Desai, H.B., Rajput, A.H., Uitti, R.J. Recurrent Spinal Cord Ischemia due to Abdominal
Aortic Aneurysm – A Case Report. Angiology 1989;40(No.7):682-687
DATATOP (A.H. Rajput – Parkinson Study Group). Deprenyl and Tocopherol
Antioxidative Therapy of Parkinsonism. Acta Neurol Scand 1989;126:171-175
Parkinson Study Group (A.H. Rajput). Effect of Deprenyl on the Progression of Disability
in Early Parkinson’s Disease. New England J of Medicine 1989;321:1364-1371
Parkinson Study Group (A.H. Rajput). DATATOP: A multicentre Controlled Clinical Trial
in early Parkinson’s Disease. Arch Neurol 1989;46:1052-1060
Rajput, A.H. Largest Ever Parkinson’s Study Gets Underway in Saskatoon Current
Therapy. Geriatrics 1989; 2(No 2):17
Shoulson, I., Fahn, S., Langston, J.W. (A.H. Rajput – Parkinson Study Group).
Conference report of first symposium on etiology, pathogenesis, and prevention of
Parkinson’s disease. Archives of Neurology 1988;45:807-811
Rajput, A.H., Uitti, R.J., Rajput, Alex. Neurological Disorders and Services in
Saskatchewan. Neuroepidemiology 1988;7:145-151
Rajput, A.H. Uitti, R.J., Stern, W., Laverty, W., O’Donnell, K., Yuen, W.K., Dua, A.
Geography, Drinking Water Chemistry, Pesticides and Herbicides and the Etiology of
Parkinson’s Disease. Can J Neuro Sci 1987;14 :414-418
Rajput, A.H., Uitti, R.J. Paraquet and Parkinson’s Disease. Neurology 1987;37:1820
Uitti, R.J., Rajput, A.H., Rozdilsky, B., Yuen, W.K. Regional Distribution of Metals in
Human Brain. Clinical and Investigative Medicine 1987;10:10-13

January 6, 2011 23
Dr. Ali H. Rajput
Rajput, A.H., Offord, K.P., Beard, M., Kurland, L.T. A Case controlled study of smoking
habits, dementia and other illnesses in idiopathic Parkinson’s disease. Neurology
1987;37:226-232
Uitti, R.J., Rajput, A.H. Multiple Sclerosis Presenting as Isolated Oculomotor Nerve
Palsy. Can J Neuro Sci 1986;13:270-272
Kish, S.J., Rajput, A.H. Gilbert, J., Rozdilsky, B., Chang, L., Shannak, K., Hornykiewicz,
O. Elevated Gama Aminobutyric Acid Level in Striatal But Not Extrastriatal Brain
Regions in Parkinson’s Disease: Correlation with Striatal Dopamine Loss. Annals of
Neurology 1986;20:26-31
Rajput, A.H., Uitti, R.J. When to use Levodopa in parkinsonism. Lancet 1986;1:1324-
1325
Rajput, A.H. Uitti, R.J., Stern, W., Laverty, W. Early onset Parkinson’s Disease in
Saskatchewan. Can J Neurol Sci 1986;13:312-316
Uitti, R.J., Rajput, A.H., Ashenhurst, E.M., Rozdilsky, B. Cyanide Induced
Parkinsonism. A Clinicopathological Report. Neurology 1985;35:921-925
Polyzoidis, K.S., McQueen, J.D., Rajput, A.H., et al. Parkinsonism as a Manifestation of
Brain Tumor. Surg Neurol 1985;23:59-63
Rajput, A.H., Offord, K.P., Beard, C.M., Kurland, L.T. Epidemiology of Parkinsonism:
Incidence, Classification and Mortality. Annals of Neurology 1984;16:278-282 (Lead
Original Article)
Rajput, A.H., Stern, W., Laverty, S.H. Chronic Low-Dose Levodopa Therapy in
Parkinson’s Disease: An Argument for Delaying Levodopa Therapy. Neurology
1984;34:991-996 (Lead Article).
Rajput, A.H. Epidemiology of Parkinson’s Disease. Canadian J of Neurological
Sciences 1984;11(No 1):156-159
Rajput, A.H., Offord, K.P., Beard, C.M. Kurland, L.T. Essential Tremor in Rochester,
Minnesota: A 45-year study. J of Neurology. Neurosurgery and Psychiatry
1984;47:446-470
Kish, S.J., Shannak, K.S., Rjaput, A.H., Gilbert, J.J., Hornykiewicz, O. Cerebellar
Norepinephrine in Patients with Parkinson’s’ Disease and Control Subjects. Archives of
Neurology 1984;41:612-614
Sundaram, M.B.M., Rajput, A.H. Nervous System Complications of Relapsing
Polychondritis. Neurology 1983;33:513-515

January 6, 2011 24
Dr. Ali H. Rajput
Kish, S.J., Shannak, K., Rajput, A.H., Gilbert, J.J., Hornykiewicz, O. Reduction of
Cerebellar Noradrenaline in Parkinson’s Disease. Journal of Neurochemistry
1983;41(suppl):102
Rajput, A.H. Bent-Knee Pulling in the Diagnosis of Lumbar Root Lesions. Archives of
Neurology 1983;40(No 8):529
Wilson, T.W., Rajput, A.H. Amantadine-Dyuazide Interaction. Canadian Medical
Association Journal 1983;129:974-985
Ragozzino, M.W., Kurland, L.T. Rajput, A.H. Investigation of the Association between
Herpes Zoster and Parkinson’s Disease. Neuroepidemiology 1983;2:89-92
Rajput, A.H., Rozdilsky, B., Hornykiewicz, O., Shannak, K., Lee, T., Seaman, P.
Reversible Drug-Induced Parkinsonism. Clinicopathological Study of Two Cases.
Archives of Neurology 1982;39:644-646
Rajput, A.H., Rozdilsky, B. Orthostatic Hypertension: Sympathetic Ganglia Changes.
Annals of Neurology 1979;5(No5):498
Lee, T., Seaman, P., Rajput, A.H., Farley, I.J., Hornykiewicz, O. Receptor Basis for
Dopaminergic Supersensitivity in Parkinson’s Disease. Nature 1978;273(No5657):59-
61
Rajput, A.H., Rozdilsky, B. Dysautonomia in Parkinsonism: A Clinico-Pathological
Study. Journal of Neurology, Neurosurgery and Psychiatry 1976;39:1092-1100
Rajput, A.H., Rozdilsky, B. Postural Hypertension in Idiopathic Parkinson’s Disease –
Etiopathology. Neurolagia-Neurocirugia-Psiquiatria (Mexico) 1976;17(No4)
Rajput, A.H., Rozdilsky, B. Parkinsonism and Dementia: Effects of L-Dopa. The Lancet
1975;1:1084
Rajput A.H., Jamieson, H., Hirsh, S., Quraishi, A. Relative Efficacy of Alcohol and
Propranolol in Action Tremor. Canadian J of Neurological Sciences 1975;2(No1):32-35
Rajput, A.H. Levodopa in Dystonia Musculorum Deformans. Lancet 1973;1:432
Keegan, D.L., Rajput, A.H. Drug-Induced Dystonia Tarda: Treatment with L-Dopa.
Diseases of the Nervous System 1973;34:167-169
Rajput, A.H. Propranolol in Essential Tremor. The Lancet 1972;1:1117
Rajput, A.H., Chornell, G., Rozdilsky, B. Progressive External Ophthalmoplegia with
Parkinsonism and Dementia Treatment with L-Dopa. Canadian J of Ophthalmology
1972;7:368-374

January 6, 2011 25
Dr. Ali H. Rajput
Rajput, A.H., Kazi, E.H., Rozdilsky, B. Striatonigral Degeneration Responses to L-Dopa
Therapy. J of Neurological Sciences 1972;16:331-341
Abud-Ortega, A.F>, Rajput, A.H., Rozdilsky, B. Observations in Five Cases of
Spontaneous Cerebellar Hematoma. Canadian Medical Association J 1972;106:40-42
Marjerrison, G., Boulton, A.A., Rajput, A.H. EEG and Urinary Non-Catecholic Amine
Changes During L-Dopa Therapy. Disease of the Nervous System 1971;33:164-169
Marjerrison, G., Boulton, A.A., Rajput, A.H. EEG Effect of L-Dopa Therapy in
Parkinsonism. Electroencephalo-Clinical Neurophysiology 1971;32:635
Marjerrison, G., Boulton, A.A., Rajput, A.H. Dopa Therapy in Parkinsonism Effect in the
EEG and Metabolism. Inter-National J of Pharmacology 1971;4(No 2):263-266
Rajput, A.H., Rozdilsky, B. Extradural Hematoma Following Frontal Sinusitis. Archives
of Otolaryngology 1971;94:83-86
Rajput, A.H. Advances in Medical Treatment of Parkinsonism. The Pakistan Medical
Review 1971;6(No2):683-686
Rajput, A.H. Role of a Neurologist in Modern Medicine. Pakistan Medical review
1970;5:251-255
Rajput, A.H., Rozdilsky, B., Emson, H. Herpes Zoster Encephalitis. The Pakistan
Medical Review 1970;4:17-22
Rajput, A.H., Robertson, D.M., Frame, R. Necrosis of Brain Following Radiation for
Basal Cell Carcinoma. The Pakistan Medical Review 1970;5:131-135
XIII. PAPERS IN NON-REFERRED JOURNALS
Rajput AH. Long Term Effects of Early Levodopa Therapy. Moving Along
2003:5(4):5&7
Rajput AH, Rajput Alex. Parkinsonian Dementia: Diagnosis, Differentiation and
Principles of Treatment. Geriatrics and Aging 2002;Vol 5, Num 4;40-44.
Rajput, A.H. Epidemiology of Parkinsons. Report from CCNS. Nov 1997.
Rajput, A.H. (Editor) Parkinson’s Disease. Practical Patient Management. Scientific
Education Services.

January 6, 2011 26
Dr. Ali H. Rajput
Rajput. A.H. Pergolide in Parkinson’s Disease. Today’s Therapeutic Trends, 1994,
12(2), 3 rd Quarter.
Rajput, A.H. Environmental Causation of Parkinson’s disease. Parkinson/Alzheimer
Digest, June 1994, 10-11.
Rajput, A.H. Deprenyl in Parkinson’s Disease. (Editorial) International Abstracts.
Apr/May/June 1993.
Rajput, A.H., Rescue of dying Neurons. (Editorial)International Abstracts Apr/May/June
1993.
Rajput, A.H. Long Term Effects of Deprenyl and Levodopa. (Editorial) International
Abstracts. Apr/May/June 1993.
Rajput, A.H. Levodopa – The most effective drug for Parkinsonian Symptoms.
(Editorial) International Abstracts. Apr/May/June 1993.
Rajput, A.H. Common Tremor Disorders. Geriatrics, March 1993.
Rajput, A.H., Rozdilsky, B., Rajput, A. Accuracy of Clinical Diagnosis in Parkinsonism –
A prospective Study. (abstracted in Focus of Parkinson’s Disease Vol 4, issue 2, pg 37-
38, 1992.)
Rajput, A.H., Rozdilsky, B., Rajput, A. Accuracy of Clinical Diagnosis in Parkinsonism –
A prospective Study. Parkinson’s/Alzheimer’s Digest 2:10-11, 1992
Rajput, A.H., Rozdilsky, B., Ang, L. Occurrence of Resting Tremor in Parkinson’s
disease. Parkinson’s/Alzheimer’s Digest, Oct. 1991.
Rajput, A.H. The Pathology of Essential Tremor. International Tremor Foundation
Newsletter, Sept 1991
Rajput, A.H. True prevalence of Parkinson’s syndrome may be 25 Percent Higher.
Parkinson Research Newsletter, July 1991
Rajput, A.H., Rozdilsky, Ang, L. Resting Tremor always present in idiopathic
Parkinson’s disease. International Medical News Group, Dec 1991.
Rajput, A.H. Parkinson’s Disease. New Sask. J of Medicine, Vol 2, No 2,P 31, Jan
1991
Rajput, A.H. Diagnosis of Initial Treatment of Parkinson’s Disease. Synapse
(Neurosciences Division, Canadian Physiotherapy Assn. Quarterly Newsletter)Apr 1990

January 6, 2011 27
Dr. Ali H. Rajput
Rajput, A.H. Parkinsonism and Neurofibrillary Tangle Pathology in Pigmented Nuclei.
Parkinson/Alzheimer Digest 2:9-11, 1990.
Rajput, A.H. Diagnosis and Initial Treatment of Parkinson’s Disease. THE
PARKINSONIST. Pub. The Medicine Group, Vol 2,No 1, 1-4, 1989
Rajput, A.H. Epidemiology and Etiology of Parkinson’s Disease. A Round Table
Discussion on Current and Future Trends in Treatment and Quality of Life, by MES
Med. Education Services, 2-6, 1988
Rajput, A.H. Little Evidence that Smoking Prevents Parkinson’s Disease. Letter to the
Editor, The Medical Post, March 1988.
Rajput, A.H., Offord, K., Beard, M., Kurland, L. A case-control study of smoking habits,
dementia and illnesses in idiopathic Parkinson’s disease. In International Medical News,
1987.
Rajput, A.H., Offord, K., Beard, M., Kurland, L. A case-control study of smoking habits,
dementia and illnesses in idiopathic Parkinson’s disease. In International Synopsis,
1987.
Rajput, A.H. Parkinson’s Disease in the Elderly. MEDICINE North America. 1:38:101-
106, 1986
Rajput, A.H. Drug Induced Parkinsonism in the Elderly. Geriatric Medicine Today,
3:99-107, 1984
Rajput, A.H. Chronic Low-Dose Levodopa, in the International Medical News Group,
1984
Rajput, A.H. Drug-induced Parkinsonism. Transition Medicine and the Aging Process,
1983.
Rajput, A.H. Recent Advances in Diagnosis and Treatment of Parkinsonism.
Continuing Medical Education News, Saskatchewan, Jan/Feb, 5-6, 1982
Rajput, A.H. Is Multiple Sclerosis Caused by a Virus? Continuing Medical Education
News, 6, No 4:4-5, 1976
Rajput, A.H. Drug Therapy in Common Neurological Disorders. Canadian Family
Physician, 21, No 11:52-56, 1975
Rajput, A.H. Polyneuropathy. Canadian Family Physician, 20, No 12:37-41, 1974.
Rajput, A.H. Parkinsonism and L-Dopa. Continuing Medical Education New. 4, No 4,
1973.

January 6, 2011 28
Dr. Ali H. Rajput
Rajput, A.H. Management of First Seizure in a Child. Saskatchewan Medical Quarterly
– Continuing Medical Education, 3, No 6, 1, 1972
Rajput, A.H. Current Status of L-Dopa in Treatment of Parkinsonism. Saskatchewan
Medical Quarterly, 34:1-5, 1970.
XV. CONTRIBUTED PAPERS IN PUBLISHED CONFERENCE PROCEEDINGS
AND ABSTRACTS
Rajput AH, Robinson CA, Rajput ML, Rajput A. Specificity of Purkinje cell loss in
essential tremor. Presented at the 62 nd Annual American Academy of Neurology
Annual Meeting, April 10-17, 2010, Toronto. Neurology 2010; 74 (suppl 2): A348.
Louis ED, Faust P, Vonsattel JP, Honig L, Rajput A, Rajput A, Pahwa R, Lyons K, Ross
W, Elble R, Erickson-Davis C. Torpedoes in essential tremor, Parkinson’s disease,
Alzheimer’s disease, and control brains. Presented at the 61 st Annual American
Academy of Neurology Annual Meeting, April 25-May 2, 2009, Seattle. Neurology 2009;
72 (suppl 3): A101.
Voll AR, Rajput ML, Rajput AH, Robinson CA, Rajput AH. Course of Parkinson’s
disease (PD) motor subtypes – longitudinally followed autopsy confirmed cases.
Presented at the 12 th International Congress of Parkinson’s Disease and Movement
Disorders, MDS (Movement Disorders Society) International Congress, June 22-26,
2008, Chicago. Movement Disorders 2008; 23 (suppl 1): S331.
Rajput AH, Luo C, Rajput AH, Rajput ML, Robinson CA. Purkinje cell (PC) count and
glutamic acid decarboxylase (GAD) in essential tremor (ET) cerebellum. Presented at
the 12 th International Congress of Parkinson’s Disease and Movement Disorders, MDS
(Movement Disorders Society) International Congress, June 22-26, 2008, Chicago.
Movement Disorders 2008; 23 (suppl 1): S388-389.
Rajput AH, Maxood K, Rajput AH. Improvement of Essential Tremor after Cerebellar
Hemorrhage. Presented at the 60 th Annual meeting of the American Academy of
Neurology, April 12-19, 2008, Chicago. Neurology 2008; 70 (suppl 1): A176.
Louis ED, Faust PL, Vonsattel JP, Honig LS, Rajput A, Robinson CA, Rajput A, Pahwa
R, Lyons K, Ross W. Neuropathological Changes in Essential Tremor: A Postmortem
Study of 33 Cases Compared with 21 Controls. Presented at the 60 th Annual meeting
of the American Academy of Neurology, April 12-19, 2008, Chicago. Neurology 2008;
70 (suppl 1): A120.
Rajput A, Robinson C, Rajput A Sr. Benign tremulous parkinsonism: Clinical and
pathological study. Presented at the XVIIth World Federation of Neurology World
Congress on Parkinson’s Disease and Related Disorders, December 9-13, 2007,

January 6, 2011 29
Dr. Ali H. Rajput
Amsterdam. Parkinsonism and Related Disorders 2007; 13 (suppl 2): S37-S38.
(Personal poster presentation)
Rajput A, Voll A, Rajput ML, Robinson C, Rajput A Sr. Course of akinetic/rigid and
tremor dominant Parkinson’s disease. Presented at the XVIIth World Federation of
Neurology World Congress on Parkinson’s Disease and Related Disorders, December
9-13, 2007, Amsterdam. Parkinsonism and Related Disorders 2007; 13 (suppl 2): S39.
Rajput A, Maxood K, Rajput A Sr. Cerebellar hemorrhage modifies essential tremor.
Presented at the XVIIth World Federation of Neurology World Congress on Parkinson’s
Disease and Related Disorders, December 9-13, 2007, Amsterdam. Parkinsonism and
Related Disorders 2007; 13 (suppl 2): S71.
Biglan KM, Schwid S, Eberly S, Blindauer K, Fahn S, Goren T, Kieburtz K, Oakes D,
Plumb S, Siderowf A, Stern M, Shoulson I. Rasagiline improves quality of life in
patients with early Parkinson’s disease. Mov Disord. 2006 May; 21(5):616-23.
Goetz CG, Schwid SR, Eberly SW, Oakes D, Shoulson I, Parkinson Study Group
TEMPO and PRESTO Investigators. Safety of Rasagiline in elderly patients with
Parkinson disease. Neurology. 2006 May 9;66(9); 1427-9.
Pasha MK, Miyashita HK, Rajput AH. Accumulation of alanine in striatum of a rotenone
rat model of Parkinson’s disease. Presented at 8 th International Congress of
Parkinson’s Disease and Movement Disorders in June 14-17, 2004. Rome, Italy.
Movement Disorders 2004:19(9):S4O
Rajput Alex, Camicioli R, Reece C, Rajput ML, Rajput AH. COMT alleles and motor
fluctuations in autopsy verified Lewy body Parkinson’s disease. Presented at 8 th
International Congress of Parkinson’s Disease & Movement Disorders in Rome, Italy:
June 14-17, 2004: Movement Disorders 2004:19(Suppl 9):S171
Rajput Alex, Camicioli R, Reece C, Rajput ML, Rajput AH. COMT alleles and levodopa
complications in Parkinson’s disease. Presented at 39 th Meeting of the Canadian
Congress of Neurological Sciences in Calgary, Alberta: June 8-12, 2004: The Canadian
Journal of Neurological Sciences 2004:31(Suppl 1)S30
Pasha MK, Sharma RK, Miyashita H, Rajput AH, Selvakumar P, Rajput Alex.
Increased N-myristoyltransferase activity in cardiac muscle of rotenone rat model of
Parkinson’s disease. Presented at 39 th Meeting of the Canadian Congress of
Neurological Sciences in Calgary, Alberta: June 8-12, 2004: The Canadian Journal of
Neurological Sciences 2004:31(Suppl 1) S58
Rajput Alex, Pasha MK, Philibert H, Robinson CA, Resch L, Rajput. AH.
Pathological Study of Early Mortality in Rotenone-Treated Rats. Presented at
American Academy of Neurology 56 th Annual Meeting in San Francisco: April 24-
May 1, 2004: Neurology 2004:62(Suppl5):A10.

January 6, 2011 30
Dr. Ali H. Rajput
Pasha MK, Sharma RK, Miyashita H, Rajput Alex, Selvakumar P, Rajput AH. Increased
N-myristoyltransferase Activity in Cardiac Muscle of Rotenone Rat Model of Parkinson’s
Disease. Presented at American Academy of Neurology 56 th Annual Meeting in San
Francisco: April 24-May 1, 2004: Neurology 2004:62(Suppl5):A10-A11.
Camicioli R, Rajput Alex, Rajput M, Reece C, Payami H, Hao C, Rajput AH. Apo E4 is
Associated with Increased Alzheimer Pathology in Autopsy Proven Parkinson’s
Disease. Presented at International Dementia with Lewy Body Congress in Newcastle,
UK. September 2003
Rizzu P, Bonifati V, Ravid R, Rajput AH, Heutink P. Comparing Region-Specific mRNA
Expression Profiles in Progressive Supranuclear Palsy. Movement Disorder 2002:17
(Suppl 5). Presented at 7 th International Congress of Parkinson’s Disease and
Movement Disorder Meeting in Miami, Florida, November 10-14, 2002.
Rajput Alex, Robinson C, Rajput AH. Essential tremor evolution – a clinicopathologic
study. To be presented at the 37 th Meeting of the Canadian Congress of Neurological
Sciences. June 18-22, 2002 in Vancouver, BC. (Personal platform presentation.)
Rajput Alex, Robinson C, Rajput AH. Longitudinal Study of Essential Tremor: 21
Autopsy Cases. Neurology 2002:58 (Supple 3):A253-254. Presented at the American
Academy of Neurology April 2002 (Invited by American Academy of Neurology for
Highlights of the meeting).
Nichols WC, Pankratz ND, Uniake SK, Pauciulo MW, Halter C, Rudolph A, Conneally
PM, Foroud T, Rajput AH and the Parkinson Study Group. Stratification by Linkage
Rather Than Age of Onset Identifies More Parkin Mutation Positive, Parkinson Disease
Families. Presented in Denver Colorado, April 13 – 20, 2002.
Pakratz ND, Nichols WC, Uniake SK, Rudolph A, Halter C, Shults C, Conneally PM,
Foroud T, Rajput AH and the Parkinson Study Group. Genome screen to identify loci
contributing to the susceptibility for Parkinson Disease. Denver, Colorado, April 13-20,
2002.
Reider C, Halter C, Castelluccio P, Foroud T, Rajput AH and the Parkinson Study
Group. Differences in duration from parkinsonian symptom onset to diagnosis among
concordantly affected siblings. Denver, Colorado, April 13-20, 2002.
Rajput Alex, Robinson C, Rajput AH. Longitudinal Study of Essential Tremor: 21
Autopsy Cases. Neurology 2002:58(Suppl 3):A253-254. Presented at the American
Academy of Neurology April 2002 (Invited by American Academy of Neurology for
Highlights)

January 6, 2011 31
Dr. Ali H. Rajput
Reider C, Halter C, Castelluccio P, Foroud T, Parkinson Study Group (Rajput AH).
Difference in Duration from Parkinsonian Symptom Onset to Diagnosis among
Concordantly Affected Siblings. Presented at the American Academy of Neurology April
2002. Neurology 2002:58(Suppl 3):A108 (Progeni Study)
Holloway RG, Parkinson Study Group (Rajput AH). Pramipexole versus Levodopa as
Initial Treatment for Parkinson Disease: A Four-Year Randomized Controlled Trial.
Presented at the American Academy of Neurology, April 2002. Neurology
2002:58(Suppl 3):A81
Nichols WC, Pankratz ND, Uniacke SK, Pauciulo MW, Halter C, Rudolph A, Conneally
M, Foroud T, Parkinson Study Group (Rajput AH). Stratification of Linkage Rather than
Age of Onset Identifies More Parkin Mutation Positive, PD Families. Presented at the
American Academy of Neurology April 2002. Neurology 2002:58(Suppl 3):A409-410.
Rajput AH, Hornykiewicz O, Deng Y, Birdi S, Miyashita H, Macaulay R. Increased
Noradrenaline Levels in Essential Tremor Brain. Chosen as Movement Disorder
Highlight at American Academy of Neurology 53 rd Annual Meeting, Philadelphia,
Pennsylvania. May 5-11, 2001. Neurology 2001;56(Supp 3):A302
Rajput AH. Levodopa is Not Toxic to Human Substantia Nigra Neurons. Presented at
Fifth International Symposium on the Treatment of Parkinson’s Disease in Kobe, Japan,
Sept 30-Oct 1, 2000.
Thompson PD, Rajput AH. Treatment Strategies of Parkinson’s Disease. Presented at
Fifth International Symposium on the Treatment of Parkinson’s Disease in Kobe, Japan,
Sept 30-Oct 1, 2000.
Rajput, AH, Fenton ME, Sitte H, Pift C, Hornykiewicz O. Parkinsonian Tremor is
Linked to Globus Pallidus Dopamine Metabolism. 6 th International Congress of
Parkinson Disease and Movement Disorders. June 11-15, 2000 Barcelona
Bressman S, Shulman LM, Tanner C, Rajput AH., Shannon K, Borchert L, Wright
EC. Long-term Safety and Efficacy of Pramipexole in Early Parkinson’s Disease.
6 th International Congress of Parkinson Disease and Movement Disorders. June
11-15, 2000 Barcelona
Rajput AH, Fenton ME, Sitte H, Pift C, George D, Macaulay R, Hornykiewicz O.
Major Motor Complications of Levodopa Therapy Do Not Represent Spectrum of
the Same Pathophysiology. 6 th International Congress of Parkinson Disease and
Movement Disorders. June 11-15, 2000 Barcelona
Rajput AH, Birdi S, Nomani S, Fenton M, George D, Macaulay R, Robinson C. PSP
clinical diagnosis – problems and confounding factors. 6 th International Congress
of Parkinson’s Disease and Movement Disorders. Barcelona, Spain June 11-15,
2000

January 6, 2011 32
Dr. Ali H. Rajput
Rajput AH, Fenton M, Birdi S, Macaulay, George D, Rozdilsky B, Hornykiewicz O.
Brain Bank Material Versus A Single Clinic Brain Collection in Movement
Disorders Studies. XIII International Congress on Parkinson’s Disease,
Vancouver, Canada, July 24-28, 1999.
Rajput AH, Rajput, K, Rajput M, Rajput A, Rajput R. Clinical Epidemiology and
Scientific Studies at Movement Disorder Clinic Saskatoon.
Rajput AH, Rajput K, Rajput M, Rajput Alex, Rajput R. One Neurologist Movement
Disorder Clinic as a source of Parkinson Syndrome (PS) Epidemiology. XIII
International Congress on Parkinson’s Disease, Vancouver, Canada July 24-28, 1999
Bressman SB, Shulman LM, Tanner CM, Rajput AH, Shannon KM, Write E. Long-Term
Safety and Efficacy of Pramipexole in Early Parkinson’s Disease.
Sitte H, Fenton ME, Pifl C, Rajput AH, Hornykiewicz O. Globus Pallidus (GP)
Dopamine (DA) Metabolism and Parkinson’s Disease (PD) Manifestations.
Koller WC, Brin MF, Doucette J, Lyons K, Alder C, Comella C, Friedman J, Manyam B,
Matsumoto R, Rajput AH, Sethi K, Tanner C. Double Blind Assessment of Botulinum
Toxin Type A (Botox) for Essential Hand Tremor. 51 st Annual Meeting American
Academy of Neurology, Toronto, Ontario April 17-24, 1999.
Furukawa Y, Nygaard TG, Shimadzu M, Hornykiewicz O, Rajput AH, Kish SH. Brain
pterins, dopamine and dopamine transporter in patients with hereditary progressive and
dopa-responsive dystonia. Fifth International Congress of Parkinson’s Disease and
Movement Disorders, New York NY, October 10-14, 1998
Rajput AH, Birdi S, Fenton M. George D, Macaulay R, Senthilselvan A. Levodopa
Response Patterns in idiopathic Parkinson’s Disease. Fifth International Congress of
Parkinson’s Disease and Movement Disorders, New York NY, October 10-14, 1998
Nataraj A, Rajput AH. Parkinson’s disease and Comorbid Disorders. Presented at
Canadian Congress of Neurological Sciences Meeting, Montreal, June 16-20, 1998.
Fenton ME, Macaulay R, Rajput AH. Correlation between the number of substantia
nigra cells and dyskinesia, wearing off and on off in Parkinson’s disease.
Rajput AH, Fenton ME, Sitte H, Pifl C, Hornykiewicz O. Biochemical basis of chronic
levodopa complications in Parkinson’s disease.
Nataraj A, Rajput AH. Transient alien hand syndrome. Presented at Canadian
Congress of Neurological Science meeting, Montreal, June 16-20, 1998.
Baerg KL, Stewart BJ, Rajput AH. Autosomal dominant familial ALS pedigree with
SOD1 mutation and prolonged survival. Presented at Canadian Congress of
Neurological Science meeting, Montreal, June 16-20, 1998.

January 6, 2011 33
Dr. Ali H. Rajput
Nataraj A, Rajput AH. Poliomyelitis and later development of Parkinson’s disease.
Presented at Canadian Congress of Neurological Science meeting, Montreal, June 16-
20, 1998.
Nataraj A, Rajput AH. Conjugal Parkinson’s disease. Presented at Canadian Congress
of Neurological Science meeting, Montreal, June 16-20, 1998.
Nataraj A, Macaulay R, George D, Nyssen J, Rajput AH. Progressive generalized
dystonia in the elderly. Presented at Canadian Congress of Neurological Science
meeting, Montreal, June 16-20, 1998.
Rajput AH, Fenton ME, Sitte H, Pifl C, Hornykiewicz O. Brain dopamine (DA
metabolism in dyskinesia and wearing off in idiopathic Parkinson’s disease (PD).
Presented at American Academy of Neurology meeting, Minneapolis MN, Apr 25-May 2,
1998.
Isozumi K, Kaplan H, Deng H-X, Hung W-Y, Sasaki T, Siddique T, Rajput AH, Fenton
ME, George D, Kanigan B. A large Saskatchewan Kindred with Lewy body Parkinson’s
disease: Exclusion of 4q21-q-q23, Yp-pseudoautosomal region and dopamine B-
Hydroxylase locus. Presented at Canadian Congress of Neurological Sciences,
Saskatoon, SK, June 24-28, 1997.
Rajput A, Wallukait M, Rajput AH. 18 month prospective study of Amantadine (Amd) for
dopa (LD) induced dyskinesia (DK) in idiopathic Parkinson’s disease. Presented at
Canadian Congress of Neurological Sciences, Saskatoon, SK, June 24-28, 1997.
Fenton ME, Rajput AH, Uitti RJ, George D, Birdi S. Amantadine (Amd) effectiveness in
treatment of progressive supranuclear palsy (PSP) and multiple system atrophy (MSA).
Presented at Canadian Congress of Neurological Sciences, Saskatoon, SK, June 24-
28, 1997.
Bernecki BA, Yeung M, Rajput AH. Bilateral medullary pyramid infarct with spastic
onset. Presented at Canadian Congress of Neurological Sciences, Saskatoon, SK,
June 24-28, 1997.
Birdi S, Rajput AH, Fenton ME, George D, Macaulay R. Levodopa (LD) response
profile in idiopathic Parkinson’s disease (PD): A clinical-pathological study. Presented
at Canadian Congress of Neurological Sciences, Saskatoon, SK, June 24-28, 1997.
Furukawa Y, Rajput AH, Nygaard T, Shimadzu M, Hornykiewicz O, Kish S, Striatal
biopterin levels are reduced in patients with dopa-responsive dystonia and Parkinson’s
disease. Presented at XII International Symposium on Parkinson’s Disease, London,
England, March 23-26, 1997

January 6, 2011 34
Dr. Ali H. Rajput
Rajput AH, Jankovic J, McDermott M, The Parkinson Study Group. Diagnostic
accuracy in early Parkinson’s Disease. Presented at 49 th American Academy of
Neurology meeting, Boston MA, April 12-19, 1997
Toth CC, Rajput AH. Anomalies of asymmetry of clinical signs in Parkinsonism.
Presented at 49 th American Academy of Neurology meeting, Boston MA, April 12-19,
1997
Rajput, Alex, Uitti RJ, Lang AE, Rajput AH, Kumar R, Galvez-Jiminez N. Amantadine
(Amd) ameliorates levodopa (LD) induced dyskinesia (DK). Presented at 49 th American
Academy of Neurology meeting, Boston MA, April 12-19, 1997
Furkawa Y, Rajput AH, Nygaard T, Hornykiewicz O, Kish S. Biopterin biosynthetic
abnormality in brains of patients with hereditary progressive and dopa-responsive
dystonia. Presented at Third International Dystonia Symposium, Miami FL, Oct 9-11,
1996.
Birdi S, Rajput AH, Nair CPV. Progressive upper limb action dystonia and muscle
hypertrophy. Presented at Third International Dystonia Symposium, Miami FL, Oct 9-
11, 1996.
Rajput AH, Uitti RJ, Fenton ME, George D. Multiple system atrophy (MSA) and
progressive supranuclear palsy (PSP) treated with amantadine. Presented at
PSG/MDS Tenth Annual Symposium, Miami FL, Oct 1996.
Rajput AH, Fenton ME. Levodopa is not toxic to Nondegenerating substantia nigra
cells. Presented at Canadian Society for Clinical Investigations, Halifax NS, Sept 1996
Kakkar R, Raju RVS, Rajput AH, Sharma RK. Amantadine is a specific inhibitor of
bovine brain 60kDa Calmodulin-dependent cyclicnucleotide phosphodiesterase.
Presented at Canadian Society for Clinical Investigations, Halifax NS, Sept 1996
Rajput AH, Fenton M, Wilson W. Verification of Secondary Cases in Movement
Disorders. Presented at American Neurological Association, Washington DC, Oct 1995.
Annals of Neurology 1995:38(2):300.
Rajput AH, McHattie JD, Supranuclear Palsy and leg Myorhythmia in Whipple’s
disease. Poster presentation at Movement Disorder society and Parkinson’s Study
Group. Washington , DC, Oct 22, 1995. Movement Disorders, 1995;10(5)699-700.
Dorflinger EE, Rajput AH, Martine W, et al. Multicenter Evaluation of Tolcapone
(Tasmar) when given together with levodopa to Parkinson disease patients who exhibit
end-of-dose wearing-off. Presented at American Academy of Neurology, San
Francisco, March 1996. Neurology 1996;46(2):A474.

January 6, 2011 35
Dr. Ali H. Rajput
Gross DW, Rajput AH, Chance PF, Yeung M. Hereditary distal ulnar-median muscular
atrophy. A distinct inherited motor neuropathy. Presented at American Academy of
Neurology, San Francisco, March 1996. Neurology 1996;46(2):A337
Rajput AH, Fenton ME, Dhand A. Is levodopa toxic to non-degenerating substantia
nigra cells? Clinical evidence. Presented at American Academy of Neurology, San
Francisco, March 1996. Neurology 1996;46(2):A371
Rajput AH, Moghal S, Fenton ME, Rajput R. Prevalence of movement disorders (MD)
in elderly. Presented at 4 th International Congress of Movement Disorders, Vienna,
Austria, June 1996. Movement Disorders 1996;11(1):256.
Rajput AH, Fenton ME, George D, Rajput A, Kanigan B. Genetic and environmental
interaction and etiology of Parkinson’s disease (PD). Presented at 4 th International
Congress of Movement Disorders, Vienna, Austria, June 1996. Movement Disorders
1996;11(1):167
Rajput AH, Uitti R, Offord KP, Ho MM, Rajput A, Basran P. Levodopa (LD) use and
survival in parkinsonism (PS). Presented at 4 th International Congress of Movement
Disorders, Vienna, Austria, June 1996. Movement Disorders 1996;11(1):167
Rajput AH, Fenton ME, Wilson W, McCulloch L, Rajput A. Pattern of movement
disorders among family members. ). Presented at 4 th International Congress of
Movement Disorders, Vienna, Austria, June 1996. Movement Disorders 1996;11(1):87
Rajput AH. Is Amantadine (Amd) neuroprotective in Parkinsonism (PS). ). Presented at
4 th International Congress of Movement Disorders, Vienna, Austria, June 1996.
Movement Disorders 1996;11(1):23
Rajput AH. Implication of diagnostic accuracy to genetic studies of movement
disorders. ). Presented at 4 th International Congress of Movement Disorders, Vienna,
Austria, June 1996. Movement Disorders 1996;11(1):16.
Furukawa Y, Shimizu Y, Rajput AH, et al. GTP-cyclohydrolase I gene mutations in
HPD/DRD (hereditary progressive dystonia/dopa-responsive dystonia). ). Presented at
4 th International Congress of Movement Disorders, Vienna, Austria, June 1996.
Movement Disorders 1996;11(1):217. (This abstract was awarded Bronze medal)
Rajput AH, et al. Efficacy of Tolcapone in the treatment of Parkinson’s disease patients
experiencing wearing off phenomenon: The North American experience. ). Presented
at 4 th International Congress of Movement Disorders, Vienna, Austria, June 1996.
Movement Disorders 1996;11(1):271
Fenton ME, Rajput AH. Levodopa (LD) response patterns in idiopathic Parkinson’s
disease. ). Presented at 4 th International Congress of Movement Disorders, Vienna,
Austria, June 1996. Movement Disorders 1996;11(1):200

January 6, 2011 36
Dr. Ali H. Rajput
Kakkar R, Raju RVS, Rajput AH, Sharma RK. Inhibition of Calmodulin-dependent
nucleotide phosphodiesterase Isozymes by Deprenyl. Presented at Canadian
Congress of Neurological Sciences, London ON, June 1996. Can J Neuro Sci
1996;23(1):S77.
Parkinson Study Group (A.H. Rajput). Pterdine and S-adenosylmethionine
concentrations in CSF from unmedicated Parkinsonians and controls. Neurol
1994;44(suppl 2):A154.
Parkinson Study Group (A.H. Rajput). Electronic events coding. Controlled Clinical
Trials 1994;15:89.
Parkinson Study Group (A.H. Rajput). Verification and Tracking of records in a clinical
trial database. Controlled Clinical Trials 1994;15:92.
Parkinson Study Group (A.H. Rajput). The search for an endogenous neurotoxin in
Parkinson’s disease: TOPA and TOPA-quinone. Mov Disorders 1994; 9:482.
Parkinson Study Group (A.H. Rajput). Endpoints for the study of Parkinson’s Disease
progression. Movement Disorder Symposium, San Francisco, Oct 1994. Mov Disord
1994;9:480.
Rajput AH, George D. Rajput A. Parkinson’s Disease in Two Generations. Possible
Etiology. Movement Disorder Symposium, San Francisco, Oct 1994. Mov Disord
1994;9(4):80.
El-Ghar SA, Prasad K, Rajput AH. Reactive oxygen metabolities and essential tremor.
36 th Annual World Congress of the International College of Angiology, New York NY,
July 1994.
Rajput AH, Fenton M, Wilson W, McCulloch L, Sinke M, Kanigan B. Parkinson’s
disease diagnosis by history – Significance of genetic studies. Canadian Congress of
Neuro. Sci, Vicotria BC, June 1995. Neuro Sci, 1995;22(1):554.
Rajput AH, Fenton M, George D, Rajput, A, Kanigan B. Lewy body Parkinson’s disease
in large kindred. Canadian Congress of Neuro. Sci, Vicotria BC, June 1995. Can J
Neuro Sci, 1995;22(1):516.
Rajput AH, George D, Rajput A, Fenton M. Levodopa complications in idiopathic
Parkinson’s Disease. Canadian Congress of Neuro. Sci, Vicotria BC, June 1995. Can
J Neuro Sci, 1995;22(1):S16.
El-Ghar SA, Rajput AH, Mantha SV, Kalra J, Prasad K. Oxygen Free Radicals and
Alzheimer’s Disease. Canadian Congress of Neuro. Sci, Vicotria BC, June 1995. Can
J Neuro Sci, 1995;22(1):A69.

January 6, 2011 37
Dr. Ali H. Rajput
Rajput AH, Bolton CF, Rajput A. Dopa-sensitive nonprogressive parkinsonism in a
dizygotic twin. American Neurological Assn. San Francisco CA, Oct 1994.
Rajput AH. Environmental toxins and Parkinson’s disease. 3 rd International Congress
of Movement Disorders, Orlando FL, Nov 1994.
Parkinson’s Study Group (A.H. Rajput). Monoaminergic metabolism substance P, metenkephalin,
and biopterin metabolism in Parkinson’s Disease. Neurology
1993;43:A408.
Kirk A, Rajput AH. On drawing impairment in Parkinson’s Disease with and without
dementia. Presented at 29 th Canadian Congress of Neurological Sciences, St. John’s
Nfld, June 1994. Can J Neuro Sci;21(suppl2):S27
Ravindran J, Stewart BJ, Siemens P, Rajput AH, Rozdilsky B. Chorea as a presenting
feature of Alzheimer’s disease. Presented 29 th Canadian Congress of Neurological
Sciences, St. John’s Nfld, June 1994. Can J Neuro Sci;(suppl2):S67.
Ravindran J, Boule CAJ, Radhi JM, George D, Naik KH, Rajput AH. Rare clinical
presentation of Neurosarcoidosis. Presented 29 th Canadian Congress of Neurological
Sciences, St. John’s Nfld, June 1994. Can J Neuro Sci;(suppl2):S39.
Stewart BJ, Rajput AH. Ophthalmoplegia in Parkinsonism. Presented 29 th Canadian
Congress of Neurological Sciences, St. John’s Nfld, June 1994. Can J Neuro
Sci;(suppl2):S27.
Moghal S, Rajput AH, D’Arcy C, Rajput R. Prevalence of Movement Disorders in the
Elderly Community Residents. Presented at World Federation of Neurology, May 1994.
Gauthier S, Rajput AH, Suchowersky O, Lang A, Mendis T, Grimes D, Curran T,
Cubberley V, Wielgosz G. Canadian Multicentre Study of Initiating Sinemet CR
Treatment in Patients with Idiopathic Parkinson’s disease. Presented at 11 th
International Symposium on Parkinson’s Disease, Rome, Italy, March 1994.
Rajput AH, Uitti RJ, Ho M, Offord K, Rajput A, Basran P. Current Survival Profile in
Parkinsonism. Presented at 11 th International Symposium on Parkinson’s Disease,
Rome, Italy, March 1994.
Parkinson Study Group (A.H. Rajput). Pteridine and S-adenosylmethionine
concentrations in CSF from unmedicated parkinsonians and controls. Neurol
1994;44(suppl 2):A154.
Parkinson Study Group (A.H. Rajput). Electronic events coding. Controlled Clinical Trial
1994;14:89.

January 6, 2011 38
Dr. Ali H. Rajput
Parkinson Study Group (A.H. Rajput). Verification and tracking of records in a clinical
trial database. Controlled Clinical Trials 1994;15:92.
Parkinson Study Group (A.H. Rajput). The Search for an endogenous neurotoxin in
Parkinson’s disease: TOPA and TOPA-quinone. Mov Disord 1994;9:482.
Parkinson Study Group (A.H. Rajput). Endpoints for the study of Parkinson’s Disease
Progression. Mov Disord 1994;9:480.
Rajput Alex, Rajput AH, Rozdilsky B, Ang L. Significance of Resting Tremor in
Essential Tremor Cases. Presented at XV World Congress of Neurology, Vancouver
BC, Sept 5-10, 1993.
Moghal S, Rajput A, Rozdilsky B, Ang L, Rajput AH. Prognosis in Multiple System
Atrophy and Progressive Supranuclear Palsy – A Prospective Clinico-Pathological
Study. Presented at XV World Congress of Neurology, Vancouver BC, Sept 5-10,
1993.
Rajput Alex, Hayton RC, Rajput AH. Recurrent Seizures due to Undiagnosed Sick
Sinus Syndrome. Presented at XV World Congress of Neurology, Vancouver BC, Sept
5-10, 1993.
Uitti RJ, Rajput AH, Ahlskog JE, Offord KP, Ho MM, Prasad M. Rajput A, Basran P.
Amantadine Treatment is an Independent Predictor of Improved Survival in
Parkinsonism. Presented at XV World Congress of Neurology, Vancouver BC, Sept 5-
10, 1993.
Parkinson Study Group (A.H. Rajput). Effects of Sustained Deprenyl and Tocopherol
Therapy in Levodopa-Treated Parkinsonian Patients. Presented at 118 th Annual
Meeting of the American Neurological Assoc, Boston MA, Oct 17-20, 1993.
Parkinson Study Group (A.H. Rajput). The DATATOP Study: Cerebrospinal Fluid
Homovanillic Acid Changes in Patients with Mild, Early Parkinsonism. Presented
Seventh Annual Symposium on Etiology, Pathogenesis and Prevention of Parkinson’s
Disease. Boston MA, Oct 17, 1993.
Parkinson Study Group (A.H. Rajput). The Impact of Extended Deprenyl Treatment in
Parkinson’s disease patients not requiring Levodopa Therapy. Presented at 118 th
Annual Meeting of the American Neurological Assoc, Boston MA, Oct 17-20, 1993.
Parkinson Study Group (A.H. Rajput). Monoaminergic metabolism, substance P, Metenkephalin,
and bioptgerin metabolism in Parkinson’s Disease. Neurol 1993:43:A408
Parkinson Study Group (A.H. Rajput). Promoting enrolment in a multicentre clinical
trial. Controlled Clinical Trials 1993;13:438.

Parkinson Study Group (A.H. Rajput). Monitoring completion of Data form
discrepancies. Controlled Clinical Trials 1993;14:429.
January 6, 2011 39
Dr. Ali H. Rajput
Iyer RP, Yu P, Lam YM, Rajput AH. Urinary Biopterines in Parkinson’s Disease.
Presented at British Geriatrics Society Annual Conference, Glasgow, Scotland 1993.
Mosewich RK, Rajput AH, Ravindran J. Observations in Thirteen Patients with
Parkinsonism and Basal Ganglia Calcification. Presented at XXVIII Meeting of
Canadian Congress of Neurological Sciences, Toronto ON, June 16-19, 1993.
Rajput Alex, Rozdilsky B, Rajput AH. Simultaneous versus sequential Alzheimer’s
disease onset in Parkinsonism. Presented at American Neurological Association
meeting, Toronto ON, Oct 19/92. Annals of Neurology 32:2;241, 1992.
Rajput AH, Uitti RJ, Offord KP, Ho M, Rajput A, Basran P. Effect of early Amantadine
administration on survival in Parkinson’s disease. Presented at Movement Disorders
Symposium, Toronto ON, Oct 18/92. Movement Disorders 7:3;294, 1992.
He H, McKay G, Rajput AH, Midha KK. Development of a sensitive and specific
radioimmunoassay for benztropine. Presented Pharmacy World Congress, Leon,
France, Sept 1992. (Abs)
Rajput AH. Pathological and Neurochemical basis of essential tremor. International
Tremor Foundation Symposium. June 27, 1992. (Abs)
Rajput AH, Gibb W, Kish S, Hornykiewicz O. Dopa-responsive dystonia – clinical,
pathological and biochemical studies in one case. 2 nd International Congress of
Movement Disorders. Munnich, Germany, June 24-26, 1992. Movement Disorders, Vol
7(Suppl 1):p124, 1992.
Kalra J, Rajput AH, Mantha SV, Prasad K. Enhanced production of oxygen free
radicals in Parkinson’s Disease. 2 nd International Congress of Movement Disorders.
Munnich, Germany, June 24-26, 1992. Movement Disorders, Vol 7(Suppl 1):p62, 1992.
Rajput AH, Uitti RJ, Basran P, Ho M, Rajput A, Offord K. Survival in Parkinsonism on
Modern Therapy. 2 nd International Congress of Movement Disorders. Munnich,
Germany, June 24-26, 1992. Movement Disorders, Vol 7(Suppl 1):p77, 1992.
Rajput AH, Pahwa R, Pahwa P. Prognosis in Parkinsonism based on the onset mode.
2 nd International Congress of Movement Disorders. Munnich, Germany, June 24-26,
1992. Movement Disorders, Vol 7(Suppl 1):p77, 1992.
Rajput AH, Meleth R. Common environmental exposure and idiopathic parkinson’s
Disease. Third International Agricultural Symposium, May 12, 1992.

January 6, 2011 40
Dr. Ali H. Rajput
Rajput AH, Neurological and Behavioural effects of pesticides. Third International
Agricultural Symposium, May 12, 1992.
Pelusio, Rita M, (Parkinson Study Group – A.H. Rajput). Subject file checklists to
facilitate clinical trial close-out activities. Poster presentation. Society for Clinical Trials.
Philadelphia PA, May 11-13, 1992. Controlled Clinical Trials 1992;13:438
Levitt P (Parkinson Study Group – A.H. Rajput). Markers of Endogenous Dopamine
Synthesis in Parkinson’s disease. American Academy of Neurology, San Diego, May
1992. Neurology 42 (Suppl 3):421, 1992.
Parkinson Study Group (A.H. Rajput). CSF studies in untreated Parkinson disease:
dopamine metabolism and Xanthine. Neuro Sci Abs. 1992;18:1248.
Parkinson Study Group (A.H. Rajput). Assessment of short-term tolerability of
lazabemide (Ro 19-6327) in untreated Parkinson’s disease. Mov Dis 1991;7(suppl 1):14
Parkinson Study Group (A.H. Rajput). Factors predictive of the need for levodopa
therapy in early, untreated Parkinson’s disease. Neurol 1992;42(Suppl 3):441.
Parkinson Study Group (A.H. Rajput). Allelic variations in the MAO-A and MAO-B
genes in Parkinson Disease. Mov Disord 1992;7:289-290.
Rajput AH, Uitti RJ, Ho M, Offord K, Basran P, Rajput A. Epidemiological studies of
parkinsonism at a Movement Disorder Clinic. World Federation of Neurology Research
Group in Neuroepidemiology. San Diego CA, May 4, 1992.
Rajput AH, Pahwa R, Pahwa P. Mode of onset and prognosis in Parkinson’s disease.
American Academy of Neurology, San Diego Ca, May 1992. Neurology 42 (suppl
3):419, 1992.
Rajput AH, Kalra J, Mantha SV, Prasad K. Lipid perioxidation and oxygen free radical
activity in Parkinson’s Disease. Presented at 10 th International Symposium on
Parkinson’s Disease, Tokyo, Japan, Oct 27-30, 1991.
Rajput AH, Rozdilsky B, Ang L, Rajput A. Significance of the association between
essential tremor and parkinson’s Disease. Presented at 10 th International Symposium
on Parkinson’s Disease, Tokyo, Japan, Oct 27-30, 1991.
Rajput AH, Uitti RJ, Offord KP, Ho M, Rajput A, Basran P. Impact of levodopa on life
expectancy in parkinsonism. Presented at 10 th International Symposium on Parkinson’s
Disease, Tokyo, Japan, Oct 27-30, 1991.
Parkinson Study Group (A.H. Rajput). Homovanillic acid, other monamine metabolites,
and xanthine in parkinsonian CSF. Neurology 41 (suppl 1):379, 1991.

January 6, 2011 41
Dr. Ali H. Rajput
Parkinson Study Group (A.H. Rajput). Use of computer applications to facilitate
retroactive updates to a database. Poster presentation – Joint Meeting of Society for
Clinical Trials/International Society for Clinical Biostatistics, Brussels, Belgium July 8-
12,1991.
Rajput AH. Epidemiology and Etiology of Parkinson’s Disease. Presented at 3 rd
Canadian Conference on Neurogenerative Disease – Parkinsonism. Esteral, Quebec,
Apr 5, 1991.
Kalra J, Rajput AH, Mantha SV, Prasad K. Oxygen Free Radicals with Pathogenesis of
Parkinson’s Disease. Presented at Canadian Society of Clinical Chemists, Montreal
Quebec, June 2-6, 1991. (Awarded first prize for poster presentation)
Mosewich R, Rajput AH, Rozdilsky B, Shuaib A. Pulmonary Embolism: An
underecognized yet frequent cause of death in patients with Parkinson syndrome. Can J
Neuro Sci 18:2;261, 1991.
Rajput AH, Uitti R, Offord KP. Rajput A, Basran P. Impact of Levodopa on survival in
Parkinsonism. Can J Neuro Sci 18:2;214, 1991.
Rajput AH. Epidemiology of Common Movement Disorders. Presented at Canadian
conference of Neurological Sciences, Halifax NS, June 19, 1991.
Uitti R, Rajput AH, Offord KP, Ho M. Parkinsonism Survival in Levodopa Era.
American Academy of Neurology, Boston. Neurology 41 (Suppl 1) 190, 1991.
Rajput AH. Epidemiology and Etiology of Parkinson Syndrome. National Conference on
Parkinson’s Disease. Victoria BC, Sept 1990.
Rajput AH, Rozdilsky B, Ang L. Site(s) of Lesion and Resting Tremor. Annual
Symposium Parkinson Study Group 1990, Atlanta GA. Annals of Neurology 28, No
2:296-297, 1990.
Rajput AH, Rozdilsky B, Rajput A, Ang L. Specificity of Levodopa Response in
Parkinson Syndrome. Presented at XXV Canadian Congress of Neurological Sciences,
Banff AB, June 27-30, 1990. Can J Neuro Sci 17:215, 1990.
Rajput AH, Rozdilsky B. Essential Tremor and Parkinsonism Overlap. Presented at
XXV Canadian Congress of Neurological Sciences, Banff AB, June 27-30, 1990. Can J
Neuro Sci 17:244-245, 1990.
Parkinson Study Group (A.H. Rajput). Effect of Deprenyl on Neuropsychological
Function in Early Parkinson’s Disease. Annals of Neuro, 1990:28:297.
Parkinson Study Group (A.H. Rajput). Neuropsychological evaluation in early untreated
parkinson’s disease. Ann Neurol 1990;28:236.

January 6, 2011 42
Dr. Ali H. Rajput
Parkinson Study Group (A.H. Rajput). Smoking and Age at Onset of Parkinson’s
Disease: Analysis of the DATATOP Cohort. Annals of Neurology 1990;28:295.
Pelusio RM, Parkinson Study Group (A.H. Rajput). DATATOP: Managing an
Accelerated Trial. Controlled Clinical Trials, 1990;11:304.
Oakes D, Parkinson Study Group (A.H. Rajput). Investigator effects in a multicenter
trial for Parkinson’s disease. Controlled Clinical Trials, 1990;11:284.
Hall, WJ, Parkinson Study Group (A.H. Rajput). Statistical Issues in Monitoring a 2 x 2
Factorial Clinical Trial. Controlled Clinical Trials, 1990;11:284.
Shoulson I, Parkinson Study Group (A.H. Rajput). Deprenyl in Early Parkinson’s
disease: symptomatic versus protective efficacy. Neurology 1990;(suppl 1):40:370.
Rozdilsky B, Rajput AH, Rajput A. Diagnostic Accuracy in Lewyu Body Parkinsonism.
Presented at 42 nd Annual Meeting of American Academy of Neurology, Miami Beach
FL, April 30-May 6, 1990. Neurology 40:4(Suppl 1):169, 1990.
Kalra J, Rajput AH, Massey KL, Prasad K. Increased Production of Oxygen Free
Radicals in Parkinson’s Disease. Presented at 42 nd Annual Meeting of American
Academy of Neurology, Miami Beach FL, April 30-May 6, 1990. Neurology 40:4(Suppl
1):69, 1990.
Rajput AH, Rozdilsky B, Rajput A. Alzheimer’s Disease with Idiopathic Parkinson’s
Disease: Clinical Pharmacological and Pathological Observations. Presented at 42 nd
Annual Meeting of American Academy of Neurology, Miami Beach FL, April 30-May 6,
1990. Neurology 40:4(Suppl 1): 339, 1990.
Rajput, AH, Rozdilsky B. Evolution and Pathological Basis of Essential Tremor.
Presented at International Movement Disorder Meeting, Washington DC, April 1990.
Movement Disorders, 1990;5(Suppl 1):46
Rajput AH, Rozdilsky B, Rajput A. Parkinson Syndrome: Response to Levodopa and
the Underlying Pathology. Presented at International Movement Disorder Meeting,
Washington DC, April 1990. Movement Disorders, 1990;5(Suppl 1):49
Kalra J, Rajput AH, Massey KL, Prasad K. Role of Oxygen Free Radicals in Parkinson’s
Disease – An Increased Level of Malondialdehyde, a Lipid peroxidation product.
Presented at International Movement Disorder Meeting, Washington DC, April 1990.
Movement Disorders, 1990;5(Suppl 1):28
Rajput, AH, Uitti RJ, Rajput A. Life expectancy in Parkinsonism Today. Presented at
International Movement Disorder Meeting, Washington DC, April 1990. Movement
Disorders, 1990;5(Suppl 1):13

January 6, 2011 43
Dr. Ali H. Rajput
Rajput AH, Rozdilsky B, Kish S, Hornykiewicz O. Parkinson’s Disease Associated with
Essential Tremor. Presented at International Movement Disorder Meeting, Washington
DC, April 1990. Movement Disorders, 1990;5(Suppl 1):13
Hornykiewicz O, Kish SJ, Rajput AH. Parkinson’s Disease and Dementia.
Neurochemistry. Presented at 2 nd International Conference of Alzheimer’s and
Parkinson’s Disease, Kyoto, Japan, Nov 6-10, 1989.
Desai TH, Rajput AH. Use and Abuse of Drugsi in Elderly. Presented at British
Association for Psychopharmacology and Canadian College of
Neuropsychopharmacology meeting in Cambridge, England, June 23-26, 1989.
Rajput AH, Thiessen B. Parkinson’s Disease Onset Age in Sibships. Presented at the
American Neurological Association, New Orleans, Sept 1989
Rajput AH, Thiessen B. Idiopathic Parkinson’s Disease in Siblings – Consideration of
Etiology. Platform presentation at Canadian Congress of Neurological Sciences, Ottawa
June 15/89. Can J Neuro Sci 16:2:140, 1989
Desai HB, Rajput AH, Munoz D, Uitti RJ. Recurrent Spinal Cord Ischemia due to
Abdominal Aortic Aneurysm. Post presentation at Canadian Congress of Neurological
Sciences, Ottawa, June 15/89. Can J Neuro Sci 16:2:190, 1989
Rajput AH, Uitti RJ, Rajput A, Basran P. Parkinsonism – Onset and Mortality Update.
Platform presentation at Canadian Congress of Neurological Sciences, Ottawa June
15/89. Can J Neuro Sci 16:2:241, 1989
Rajput AH, Uitti RJ, Rajput A, Basran P. Changing Patten of Parkinsonism. Presented
at World Federation of Neurology – Neuroepidemiology Research Group. Apr 14, 1989
Kurland R, Clark S, Shoulson I, Penny J, Rajput AH (Parkinson Study Group).
Economic Impact of Protective Therapy for Early Parkinson’s Disease. Presented at
American Neurological Association, Philadelphia PA, Oct 2-5, 1988. Annals of
Neurology 24:153, 1988
Thiessen B, Rajput AH, Munoz D, Desai H. Environmental Impact on Substantia nigra
Neurons in Normal Brain. Presented at Canadian Society for Clinical Investigations and
Royal College of Physicians and Surgeons of Canada, Ottawa, Sept 23-26, 1988. Ref.
R-527, page C90.
Bennett VL, Rajput AH, Donat J, Jarrett D. Under diagnosis of Parkinson’s Disease in
the Elderly. Presented at 2 nd Annual Symposium on Etiology, Pathogenesis and
Prevention of Parkinson’s Disease. Philadelphia, Oct 2, 1988, Trans. P-5.

January 6, 2011 44
Dr. Ali H. Rajput
Bennett V, Rajput AH. Tardive Dyskinesia on Long Term doxepin Treatment.
Presented at Symposium on Drug Induced Movement Disorders (video session),
Philadelphia PA, Oct 2, 1988.
Kurland R, Clark S, Shoulson I, Penney JB, Parkinson’s Study Group (A.H. Rajput).
Economic Impact of Protective Therapy for early Parkinson’s Disease. Presented at
113 th Annual Meeting of the American Neurological association, Philadelphia PA, Oct
1988, Trans p47, page 109.
Shoulson I, Rajput AH. Antioxidative Experimental Strategies Aimed at Slowing the
Progression of Parkinson’s’ Disease. International Symposium on Alzheimer’s Disease.
June 1988, Kuopio, Finland (World Federation of Neurology Research Group on
Dementia). Publications of the University of Kuopio (ISBN 951-780-488-1), 35-36, 1988
Rajput AH, Bennett V, Uitti RJ. Early Rural Exposure as a Risk to Parkinson’s Disease
Onset in Later Age. 9 th International Symposium on Parkinon’s Disease. Jerusalem,
June 6, 1988
Shoulson I, (A.H. Rajput). Antioxidative Experimental Strategies for Parkinson’s
Disease. 9 th International Symposium on Parkinson’s Disease, Jerusalem Israel, June
1988
Rajput AH, Thiessen B, Munoz D, Laverty W, Desai H. Consideration of Age and
Environments and Number of Substantia Nigra Cells. 9 th International Symposium on
Parkinson’s Disease, Jerusalem Israel, June 1988
Rajput AH, Thiessen B, Munoz D, Laverty W, Desai H. Numerical Analysis of
Substantia Nigra Cells in General Population. Canadian Congress of Neruo Sci, June
16, 1988, Quebec City. Can J Neuro Sci 15:290, 1988
Uitti RJ, Rajput AH, Rozdilsky B, Yuen WK. Brain Metals and Chronic Neurological
Diseases. Presented at Canadian Congress of Neuro Sci, June 16, 1988, Quebec
City. Can J Neuro Sci 15:195-196, 1988
Uitti RJ, Rajput AH, Rozdilsky B, Yuen WK. Regional Metal Concentrations in Human
Brain: Chronic Neurologic Disease and Controls. Presented at American Academy of
Neurology, Cincinnati, Apr 17-23, 1988. Neurology 38:3(Suppl 1):273-274, 1988.
(Special presentation based on the research essay which was judged as best
research by a North American student and given Milton-Shy Award by the
American Academy of Neurology).
Thiessen B, Munoz D, Rajput AH, Desai H. Substantia Nigra Neuronal Counts in
Normal Rural and Urban Population. Presented at American Academy of Neurology,
Cincinnati, April 17-23, 1988. Neurology 38:3(Suppl 1):38-48, 1988.

January 6, 2011 45
Dr. Ali H. Rajput
Bennett V, Rajput AH, Uitti RJ. An Epidemiological Survey of Agricultural Chemicals
and Incidence of Parkinson’s Disease. Presented at American Academy of Neurology,
Cincinnati, April 17-23, 1988. Neurology 38:3(Suppl 1):349, 1988
Rajput AH. New Epidemiological Approach to Parkinson’s Disease. Movement Disorder
Group of Canada Symposium, Ottawa, May 22, 1987
Rajput AH, Uitti RJ, Stern W, O’Donnell K, O’Donnell D, Yuen WK, Dua A. Etiology of
Parkinson’s Disease – Environmental Factors-Geography, Herbicide and Water
Chemistry. In Symposium on Disorders of Muscle Tone. Lake Louise AB, Feb 7, 1987.
Shoulson I, (Rajput AH). Correlates of clinical decline in early Parkinson’s Disease.
Neurology (Suppl 1):278, 1987.
Desai H, Rajput AH. Recurrent Spinal Cord Ischemia due to Abdominal Aneurysm.
American Association of Angiology, 1987.
Bennett V, Rajput AH, Uitti RJ. Relationship of Agricultural Chemicals to Parkinson’s
disease. Presented at III Pan American Symposium on Neuroepidemiology, San Juan,
Puerto Rico, Oct 17, 1987.
Donat JR, Sundaram M, Rajput AH. Spinal Myoclonus: Electrophysiological
Observations and Response to Treatment. Can J Neuro Sci 14:214, 1987.
Uitti RJ, Sealey R, Rajput AH, Saleh A. Neurological Disorders/services in
Saskatchewan Treaty Natives. Canadian Congress of Neurological Sciences,
Vancouver, June 1987. Can J Neuro Sci 14:222, 1987.
Sudhakar S, Rajput AH, Rozdilsky B, Uitti RJ. A Clinicopathological Study of
Neurofibrillary Tangles in Parkinsonism. Canadian Congress of Neurological Sciences,
Vancouver, June 1987. Can J Neuro Sci 14:215, 1987.
Rajput AH, Uitti RJ, Rajput A. Neurological and Neurosurgical Procedures in
Saskatchewan. Canadian Congress of Neurological Sciences, Vancouver, June 1987.
Can J Neuro Sci 14:221, 1987.
Rajput AH, Uitti RJ, Rajput A, Wollin T. Neuroepidemiology in Saskatchewan:
Disorders and Services. Canadian Congress of Neurological Sciences, Vancouver,
June 1987. Can J Neuro Sci 14:222, 1987.
Sudhakar S, Rajput AH, Rozdilsky B, Uitti RJ. Neurofibrillary Tangles and
Parkinsonism. American Academy of Neurology, New York, April 1987. Neurology, 37
(Suppl 1):302, 1987
Sudhakar S, Rajput AH, Rozdilsky B, Uitti RJ. A Clinicopathologic Study of
Neurofibrillary Tangles in Parkinsonism. American Academy of Neurology, New York,
April 1987. Neurology, 37 (Suppl 1):278, 1987

January 6, 2011 46
Dr. Ali H. Rajput
Rajput AH, Uitti RJ, Rajput A. Pattern of Neurologic Disorders and Services in
Saskatchewan. American Academy of Neurology, New York, April 1987. Neurology, 37
(Suppl 1):302, 1987
Rajput AH, Offord K, Beard M, Kurland LT. A case controlled study of smoking habits,
dementia and other illnesses idiopathic Parkinson’s Disease in Rochester, Minnesota.
American Academy of Neurology, New Orleans, April 1986
Stoessl AJ, Marin W, Hayden M, Adam M, Ruth T, Rajput AH, Pate B, Calne D.
Dopamine in Huntington’s Disease. Studies using Positron Emission Tomography.
American Academy of Neurology, New Orleans, April 1986
Rajput AH, Uitti RJ, O’Donnell D, O’Donnell K. Metal concentration in drinking water
and Parkinson’s disease and controls. Canadian Congress of Neurological Sciences,
London ON, June 1986.
Sudhakar S, Rajput AH, Rozdilsky B, Uitti RJ. Neurofibrillary Tangles and
Parkinsonism. Royal College of Physicians and Surgeons of Canada, Toronto ON,
Sept 1986.
Rajput AH. Current Research in Parkinson’s Disease at University of Saskatchewan.
Medical Research Council 25 th Anniversary Display, Winnipeg MB, Oct 25-26, 1985 and
College of Medicine, University of Saskatchewan, Nov 11-15, 1985
Uitti RJ, Rajput AH, Rozdilsky B, Yuen WK. Regional Distribution of Metals in Human
Brain. Annual Meeting of Canadian Society for Clinical Investigations, Sept 1985. (This
paper received Student Research Award from the Canadian Society for Clinical
Investigations for R. Uitti).
Rajput AH, Uitti RJ, Rozdilsky B, Yuen WK. Distribution of Metals in Parkinson’s
Disease and Control Brains. American Academy of Neurology, Dallas TX, April 28-May
4, 1985.
Kish S, Rajput AH, Gilbert J, Rozdilsky B, Tchang LJ, Shannak K, Hornykiewicz O.
Distribution of Striatal GABA in Normal and Parkinson’s Brains. VIII International
Symposium on Parkinson’s Disease, New York City, June 9-12, 1985.
Rajput AH, Uitti RJ, Stern W, Laverty W. Relationship between Early Onset Parkinson’s
Disease and Country Living. VIII International Symposium on Parkinson’s Disease,
New York City, June 9-12, 1985.
Rajput AH, Uitti RJ, Rozdilsky B, Yuen W. Regional Metal Distribution in Parkinsonism
and Control Brains. VIII International Symposium on Parkinson’s Disease, New York
City, June 9-12, 1985.

January 6, 2011 47
Dr. Ali H. Rajput
Rajput AH, Laverty W, Stern W, Christ A. Etiology of Parkinson’s Disease.
Environmental Factor(s). American Academy of Neurology , April 1984. (This paper
was invited by the Academy for press interview).
Rajput AH. Epidemiology of Parkinson’s Disease. Special Supplement, Can J Neuro
Sci 11:1;156-159, 1984.
Rajput AH, Stern W, Christ L. Juvenile Parkinson’s Disease Response to Modern Drug
Treatment. Canadian College of Neuropsychopharmacology, Saskatoon SK, May 25-
27, 1983.
Rajput AH, Stern W, Laverty W. Long Term Efficacy of Low Dose Levodopa in
Parkinson’s Disease. American Academy of Neurology, San Diego, April 24-29, 1983.
(This paper was discussed with U.S. National press at the request of the
Academy).
Rajput AH. Epidemiology of Parkinson’s Disease. Symposium on Current Concepts
and Controversies in Parkinson’s Disease, Montebello, Quebec. Oct 21-22, 1983.
Rajput AH, Tchang S. Aphrodesia on Anti-parkinsonian Treatment. Canadian
Congress of Neurological Sciences, Newfoundland, June 22-24, 1983.
Polyzoidis K, Griebel R, Rajput AH, MacFadyen DJ, McQueen JD. Parkinsonism as a
Manifestation of Brain Tumor. Congress of Neurological Sciences, Newfoundland, June
22-24, 1983.
Rajput AH, Stern W, Christ A. Early Onset Parkinsonism. Canadian College of
Neuropsychopharmacology, Saskatoon SK, 1983.
Kish SJ, Shannak KS, Rajput AH, Gilbert JJ, Hornykeiwicz O. Reduction of Cerebellar
Noadrenaline in Parkinson’s Disease. 9 th Meeting of International Society for
Neurochemistry, Vancouver BC, July 10-15, 1983.
Rajput AH, Offord K, Beard M. Kurland LT. Epidemiological Survey of Essential tremor
in Rochester, Minnesota. Presented American Academy of Neurology, Washington DC,
April 28-30, 1982.
Rajput AH, Kurland LT. Dementia in Parkinson’s Disease. VIII International Symposium
on Parkinson’s Disease, Frankfurt, Germany, July 1982.
Rajput AH, Elveback LR, Beard M, Kuralnd LT. Epidemiology of Parkinson’s Disease in
Rochester, Minnesota. 12 th International Congress of Neurology, Kyoto, Japan, Sept
20-25, 1981.
Lucas A, Beard CM, Rajput AH, Kurland LT. Gilles de la Tourette Syndrome in
Rochester, Minnesota. Presented at First International Tourette’s Syndrome
Symposium, New York NY, May 28-29, 1981.

January 6, 2011 48
Dr. Ali H. Rajput
Rajput AH, Rozdilsky B, Hornykiewicz O, Shannak K, Lee T, Seeman P. Susceptibility
to Drug-induced parkinsonism. American Academy of Neurology, 1979.
Lee T, Seeman P, Rajput AH, Farley I, Hornykiewicz O. Parkinson’s Disease: Brain
Dopamine receptors. American Society for Pharmacology and Experimental
Therapeutics, 1978.
Rajput AH. Treatment of Dystonia. IV International Symposium on Parkinson’s
Disease, 1978.
Rajput AH, Wilson TW, MacFadyen DJ, Rozdilsky B. Essential Hypertension (HT) and
Essential Tremor (ET). Canadian Congress of Neurological Sciences, 1978.
Rajput AH. Essential tremor that is not “Benign”. 11 th Canadian Congress of
Neurological Sciences, June 23-26, 1976.
Rajput AH, Rozdilsky B. Autonomic Nervous System Lesions in Parkinson’s Syndrome.
Fourth Pan American Congress of Neurology, Mexico, 1975.
Rajput AH, Ashenhurst EM, DeCoteau WE, Rozdilsky B. Hereditary Ataxia with
Immune Deficiency and Alpha-Fetoproteinemia in Absence of Telangiectasia. Can J of
Neur Sci:1:No 4:262, 1974.
Rajput AH, Rozdilsky B. Anatomical Basis of Autonomic Dysfunctions in Parkinsonism.
Canadian Congress of Neurological Sciences, 1974.
Rajput AH. Role of Occupational Therapy in the Evaluation of Parkinsonism and
Related Disorders. World Federation of Occupational Therapists, Sixth International
Congress, Vancouver BC, Aug 12-16, 1974.
DeCoteau WE, Gerrard JW, Rajput AH. Spinocerebellar Degeneration and Ataxia
Telangiectasis in a Family with Selective IgA Deficiency. Proceedings of Canadian
Federation of Biological Scoieties, 1973.
Rajput AH, Jamieson H, Hirsh S. Specificity of Tremorilytic Effects of Alcohol and
Propranolol. Clinical Research, 21:No 5:1018, 1973.
Rajput AH, Merriman J, Weese C. Respiratory Functions in Parkinson’s Disease and
Effects of L-dopa Therapy (Report of 100 Cases). Royal College of Physicians and
Surgeons of Canada, 1972.
Rajput AH, Rozdilsky B. Incidence and Pathophysiology of EEG Abnormalities in
Parkinsonism. Clinical Research, 10:No 5:66-67, 1972.

January 6, 2011 49
Dr. Ali H. Rajput
Rajput AH, Rozdilsky B. Relation of Clinical and Pathological Findings to EEG Changes
in Parkinsonism. American Electroencephalographic Society, 26 th Annual Meeting,
1972.
Kooi SK, Rajput AH, deJong RN. Significance of paroxysmal EEG in patients with
Migraine. International Congress of Electroencephalography and Clinical
Neurophysiology, Vienna, Austria, 1965.
XVI. TECHNICAL REPORTS RELEVANT TO ACADEMIC FIELD
Submission to U.S. Congress. “Epidemiology & Etiology of Parkinson’s Disease” (by
invitation).
Review for the United States Congress, Office of Technology “Neural Grafts in Brain
and Spinal Cord” – Ethical Issues (by invitation).
XVII. BOOK REVIEWS
Parkinson’s Disease – Symposium Review 1992. J. Jankovic. Eds: Merton Sadler, Pub:
John Libbey, London, Paris, Rome. For Can J Neuro Sciences (in press).
Rajput AH. Review “Movement Disorders. A Comprehensive Survey”. Eds: W. Weiner,
A. Lang. Can J Neuro Sci 18:108 – 1991 Movement Disorders 2, C.D. Marsden and S.
Fahn (Ed) Butterworths (London) for Canadian Medical Association Journal, 138-342,
1988.
Recent Developments in Parkinson’s Disease. S. Fahn, C. Marsden, P. Jenner and P.
Teychenne (Eds.) Raven Press, New York for Can J of Neuro Sci:13, 1986.
A.H. Rajput. Review of A. Barbeau and P.H. McDowell (Eds.), L-Dopa and
Parkinsonism. Medical Post, 1971.
XVIII. INVITED LECTURES OUTSIDE U. OF S.
Guest Speaker - American Academy of Neurology, Toronto, ON., Canada – Specificity
of Purkinjie Cell Loss in Essential Tremor.
Guest Speaker – Parkinson’s Disease Conference, Winnipeg, Manitoba, October 24 &
25, 2002.
Guest Speaker – University of Regina (Awards Dinner), May 10, 2002.

January 6, 2011 50
Dr. Ali H. Rajput
Guest Speaker – International Scientific Meeting “Making Connections in Parkinson’s
Disease”, Prague February 28 – March 3, 2002.
Saskatchewan Representative to the Canadian Neurology Summit Advisory Board,
February 9 – 13, 2002.
Guest Speaker – Consensus Meeting “Levodopa: Why the Controversy?”, Zurs,
Austria, January 17 & 18, 2002.
Visiting Professor – University of Manitoba, June 8, 2001
Guest Speaker – “Practical Pearls in Geriatric Neurology” presented at: Clinical Issues
in Geriatrics, Geriatric Medicine and Psychiatry at Hotel Saskatchewan in Regina, Oct
27, 2000 and The Glenmore Inn in Calgary, AB, Nov 3, 2000.
Rajput AH. The Many Faces of PSP. Video Session presented at Fifth International
Symposium on the Treatment of Parkinson’s Disease in Kobe, Japan, Sept 30-
Oct 1, 2000.
Visiting Professor – University of Indiana, Indianapolis – Aug 10, 2000
Co-Chairman – Plenary Session “Clinical and public health issues in Parkinson’s
disease”. 6 th International Congress of Parkinson’s Disease and Movement
Disorders. Barcelona, Spain, June 11-15, 2000.
Prepared slide set on Parkinson’s Disease Teaching Slide WE MOVE Worldwide
Education and Awareness for Movement Disorders. Distribution to all neurology
residency training programs and to all U.S. medical school libraries. January
2000
Co-Chairman of Subcommittee on Pharmacological Agents in Treatment of
Parkinson’s Disease at World Federation of Neurology – Research Committee on
Parkinsonism and Related Disorders in New York, May 8, 2000
Guest Speaker – Clinical Issues in Geriatrics, Geriatric Medicine and Psychiatry.
“Practical Pearls in Geriatric Neurology”. Surrey, BC. November 26, 1999
Guest Speaker- Continuing Medical Education, University of Minnesota, November 13,
1999
Guest Speaker – Continuing Medical Education, University of Kansas, November 5,
1999
Visiting Professor at Southern & Illinois University in Springfield, IL November 1, 1999
Guest Speaker – DuPont Pharmaceuticals Advisory Board Meeting, Park City, UT.
Sept 24-25, 1999

January 6, 2011 51
Dr. Ali H. Rajput
Co-Chairman of satellite symposium “Neuroprotection and Neurodegeneration in
Parkinson’s Disease”. XIII International Congress on Parkinson’s Disease, Vancouver,
Canada July 28, 1999.
Media Interview by Pacific Parkinson’s Research Institute. XIII International Congress
on Parkinson’s Disease, Vancouver, Canada July 28, 1999.
Advisor of 2 nd Canadian Advisory Board Meeting. XIII International Congress on
Parkinson’s Disease, Vancouver, Canada July 28, 1999.
Speaker at Plenary Session: Medical Treatment of Parkinson’s Disease I. Title:
“Levodopa Toxicity”. XIII International Congress on Parkinson’s Disease, Vancouver,
Canada July 28, 1999.
Edmonton Parkinson Society Lecture. April 29, 1999.
Parkinson’s Society of Southern Alberta. Parkinson’s disease. Calgary AB, Apr 24,
1999.
Parkinson’s disease and dementia: Identifying and managing these conditions.
Presented at “Dementia” 1999 at Vancouver BC, April 10, 1999.
Managing established disease: Neurological and psychiatric updates. Presented at
“Dementia” 1999 at Vancouver BC, April 10, 1999.
‘Parkinson’s disease update’. CME, Saskatoon SK, January 19, 1999
Epidemiology of Parkinson’s Disease. Fifth International Congress of Parkinson’s
Disease and Movement Disorders. Breakfast Seminar, New York NY, Oct 14, 1998.
Late Motor complications in Parkinson’s disease. F. Merz visiting Professor. J.W.
Goethe-University, Frankfurt, Germany, June 26, 1998.
Patient Forum on Parkinson’s Disease. Frankfurt, Germany, June 24, 1998.
Epidemiology aspects in the etiology of Parkinson’s disease. Visiting Professor,
University of Lubeck, Lubeck, Germany, June 23, 1998.
Is levodopa toxic to substantia nigra. Montreal Neurological Society, PQ, June 17, 1998.
Is levodopa toxic to substantia nigra. B.C. Parkinson’s Disease Assn. Vancouver BC,
April 18, 1998.
Epidemiology of Parkinson’s disease. Montreal Neurological Institute and Hospital at
McGill Movement Disorder Meeting. April 17, 1998.

January 6, 2011 52
Dr. Ali H. Rajput
Neurological Disorders: a Burden on Society. To Rotary Club of Saskatoon, March18,
1998.
Is Levodopa Toxic? Evolving therapeutic strategies for Parkinson’s disease. Newport
Beach CA, January 17, 1998.
Movement Disorders. CME Recent Advances in Medicine, Saskatoon, Nov 28, 1997.
Late Stage of Dementia. Lecture to clinicians, psychiatrists, geriatricians in Victoria BC,
Nov 27, 1997.
Recent Advances in Parkinson’s disease – open to all physicians. Saskatoon SK, Nov
25, 1997.
Recent Advances in the treatment of Parkinson’s disease. CME Hotel Dieu Grace
Hospital, Windsor ON, Nov 10, 1997.
Diagnosis and Management of Parkinson’s disease. North Battleford District Medical
Assn. Oct 15, 1997.
Current and future new medications for Parkinson’s disease: when should they be
used? University of Iowa Hospitals and Clinics. Iowa City, Iowa, Oct 25, 1997.
Lecture on Neurological research. 5 th year dental students, U. of Sask. Oct 29, 1997.
Richardson Lecture for Canadian Congress of Neurological Sciences. Saskatoon SK,
June 1997. “An insight into neurodegenerative disease”.
Parkinson’s disease: Management of Drug Therapy. Presented at 10 th Biennial Drug
therapy ’97 CME, Regina, March 14-15, 1997.
Use of Amantadine in Progressive supranuclear Palsy and for levodopa induced
dyskinesia. NIH Symposium, Besthesda MA, Nov 22, 1996.
Rajput AH, Fenton M. Strategy to get a foothold for etiology of PD. Presented at NIH
Workshop on Parkinson’s disease, Environmental Etiology. Research Triangle Park,
North Caroline Sept 17-19, 1995.
Cortical-Basal Ganglionic Degeneration like expression of Pick’s disease. Presented at
Cortical-basal ganglionic Degeneration Symposium, Washington DC, Oct 25, 1995.
Amantadine treatment is an independent Predictor of Improvement survival in
parkinsonism. 7 th International Adamantan-Workshop. Lisbon, Spain, March 1996.
Essential Tremor. University of Iowa, Neurology Department, May 8, 1996.

January 6, 2011 53
Dr. Ali H. Rajput
Chairman Platform session. Free Communications: Session E, Movement Disorders.
Canadian Congress of Neurological Sciences, Victoria BC, June 22, 1995.
Video Session for Unusual Movement disorders. Whipple’s Disease. Canadian
Congress of Neurological Sciences, Victoria BC, June 22, 1995.
Dementia/cognitive Impairment. Investigations. Neurology Update’95, Regina SK, Jan
20-21, 1995.
Movement disorders: Selected cases. Neurology Update 95, Regina SK, Jan 20-21,
1995.
Panel: Social Aspects of Neurological impaired persons: Driver’s license Assessment
of Competence or Fitness to work. Neurology Update 95, Regina SK, Jan 20-21, 1995.
Visiting Professor. La Sapienza University, Rome Italy, Nov 25-Dec 19, 1994. Held 12
research seminars and clinical demonstrations (and several special lectures).
Special Lecture. Tremor in extrapyramidal diseases. Neurological Sciences
Department, La Sapienza University, Rome Italy, Dec 5, 1994
Special Lecture. Diagnostic accuracy of Parkinson’s Disease. Neuroloigcal Sciences
Department, La Sapienza University, Rome Italy, Dec 5, 1994
Special Lecture. Symptomatic and Protective effects of Deprenyl. Neuroloigcal
Sciences Department, La Sapienza University, Rome Italy, Dec 5, 1994
Guest Lecturer, Third National Congress on Environmental and Disease of the
Nervous System. “Environmental Factors in the pathogenesis of Parkinson’s disease.
Rome, Italy, Dec 16, 1994.
Special Lecture. Environmental Factors in Parkinson’s Disease pathogenesis. La
Sapienza University, Rome Italy, Dec 5, 1994
Special Lecture. Overview of Movement Disorders. Catholic (Vatican) Medical
College, Rome, Italy, Dec 1994.
Environmental Toxins and Parkinson’s disease. Third International Congress of
Movement Disorders, Orlando, Florida, Nov 8, 1994.
Advanced Parkinson’s Disease: Much more than tremor and bradykinesia. Practical
Health Care of the elderly, CME, Saskatoon SK, Oct 20, 1994.
Update on Parkinson’s Disease. Presented to:
District Medical Society, Waskesiu SK. June 4, 1994.
Saskatoon Community Clinic, Saskatoon SK, Sept 20, 1994.

January 6, 2011 54
Dr. Ali H. Rajput
Visiting Professor. Epidemiology of Parkinson’s Disease. Neurology Grand Rounds,
University of Iowa, May 20, 1994.
Clinical Experience in the Management of Parkinson’s disease. Hopital Charles-
LeMoyne, Greenfield Park, Quebec, March 15, 1994.
Clinical Experience in the Management of Parkinson’s disease. Hopital Maisonneuve,
Rosemont, Montreal, Quebec, March 15, 1994.
Parkinson’s Management: Clinical Implications of Controlled Release versus Immediate
Release Levodopa. Presented at: a) Hotel Vogue, Salon Lyon, Montreal, Quebec,
March 15, 1994, b) Hotel Dieu de Montreal, March 15, 1994, c) Hopital Sait Luc,
Montreal, Quebec, March 16, 1994, d) Chateau Frontenac, Quebec City, Quebec,
March 16, 1994
Update on Essential Tremor treatment with BOTOX. Allergan Advisory Meeting, Lake
Louise AB, Jan 29, 1994.
Clinical Aspects and New Advances in the early Management of Parkinson’s Disease.
Association of Community Neurologists, Toronto ON, Nov 11, 1993.
New advances in the early management of Parkinson’s disease Queen’s University,
Kingston ON, Nov 10, 1993
Lecture. Early Diagnosis and early treatment of Parkinson’s Disease. Satellite
Symposium at the XVth World Congress of Neurology, Vancouver BC, Sept 1993.
Debate presentation “Etiology of Parkinson’s disease. Environmental Factors.
Movement Disorder Symposium, Toronto ON, June 1993.
Neurology Grand Rounds. St. Michael’s Hospital, Toronto ON, April 1, 1993
Guest Speaker. Update on Parkinson’s disease. Chinese Community, Toronto ON,
March 31, 1993.
Lecture. Use of Botulinum Toxin in Dystonia. Saskatoon, SK March 9, 1993.
Lectures on Protective Therapy in Parkinson’s Disease to Australian Neurological
Society at, a) Melborne, Australia, Mar 1/93, b) Sydney, Australia, Mar 3/93, and c)
Brisbane, Australia, Mar 4, 1993.
Visiting Professor: University of New South Wales. Sydney, Australia, Mar 3,1993.
University of Melbourne, Australia, March 2, 1993.
Monash Medical Centre. Melbourne, Australia, March 2, 1993.
Queensland University. Brisbane, Australia, March 5, 1993

January 6, 2011 55
Dr. Ali H. Rajput
Special Training on BOTOX in Essential Tremor. Research. Kansas City KS, Jan 29,
1993.
Visiting Professor, Grand Rounds. “Risk Factors for Parkinson’s Disease”. University
of Kansas, Kansas City KS, Jan 29, 1993
Lecturer. Biological Psychiatry Course. Parkinson’s/Huntington’s. Jan 6, 1993.
Meadow Lake and District Medical Society. Continuing Medical Education, Jan 7, 1993.
Lecture to National Health Protection Branch. “Clinical problems with long term
treatment of Parkinson’s’ disease with levodopa. Ottawa, Dec 7, 1992.
Lecture. Lazabemide: A Clinical Prospective at Hoffman-LaRoche Investigators
Meeting on Lazabemide in Alzheimer’s disease. Nov 13, 1992.
Psychology Seminar. Recent Advances in Parkinson’s Disease. Nov 3, 1992.
Visiting Professor. Windsor ON, Sept 8, 1992.
Grand Rounds – Hotel Dieu Hospital, Dept of Medicine
Clinical Case presentations and discussions with local neurologists.
Lecture, Deprenyl and Parkinson’s disease. CCNP, Saskatoon SK, June 2, 1992
Lecture, Parkinson’s Disease, Gerontology for Nurses, Saskatoon, May 28, 1992
Visiting Professor. University of Alberta, Edmonton AB. Presented Neurology Grand
Rounds, May 27, 1992
Lecture. Parkinson’s Disease Update. Edmonton Family Physicians. Edmonton AB,
May 26, 1992
Co-Chairman, Third International Symposium: Issues in Health, Safety & Agriculture.
“Effects of Pesticides II: Clinical effects and differential diagnosis: Treatment and
Prevention.” Saskatoon SK, May 12, 1992.
Special Course, American Academy of Neurology. Controversies and Consensus in
Neurology. “The environmental causation of Parkinson’s’ Disease”, San Diego, May 9,
1992.
Saskatoon City Hospital Grand Rounds. “Parkinson’s Disease”. Apr 24, 1992
Case Studies: Sinemet CR in newly-diagnosed patients with Parkinson’s Disease –
common findings. The Medicine Group, Toronto ON, Apr 24-25, 1992

January 6, 2011 56
Dr. Ali H. Rajput
Lecture, “Update on Parkinson’s Disease”, CME Prince Albert SK, Mar 19, 1992.
An update on DATATOP Study at Deprenyl Advisory Committee Meeting, Paul Spring
CA, Feb 21, 1992.
Lecture, “Management of Parkinson’s disease”, CME, Regina SK, Feb 3, 1992.
Lecture, “Botulinum Toxin in Dystonia”, In-service for 6300 nurses, Jan 31, 1992.
Lecture, “Evaluation, Clinical Changes & New Horizons”, Parkinsonism Symposium,
Winnipeg MB, Dec 6, 1992/
Visiting Professor. University of Manitoba. “Basal Ganglia Pharmacology”, Winnipeg,
Dec 6, 1991.
Lecture. “New Developments in Parkinson’s Disease, Winnipeg Family Phsicians, Dec
5, 1991.
Lecture, “Parkinson’s disease Update New Treatment Strategies” to nurses, general
practitioners, gerontologists at Deer Lodge Geriatric Hospital, Winnipeg MB, Dec 5,
1991 (2 – one hour talks).
Lecture. “Parkinson’s Disease” to general practitioners, Selkirk MB, Dec 4, 1991
Lecture. “Recent Advances in the Management of Parkinson’s disease”, North
Battleford & District Medical Society, Nov 20, 1991.
Round Table conference on Parkinson’s disease with 12 world experts in the field, Oct
30, 1991 (published).
Invited participant. Mini conference on DRD & related disorders. Juntendo University
Hospital, Tokyo, Japan, Oct 31, 1991.
Session Chairman. Epidemiology. 10 th International Symposium on Parkinson’s
Disease, Tokyo, Japan, Oct 29, 1991.
Lecture. “Update on the Management of Parkinson’s Disease” to:
Continuing Pharmacy Education, Regina SK, Oct 20, 1991.
U of S Campus, Saskatoon SK, Oct 9, 1991
Lecture. “Update on Parkinson’s Disease”, Carrot River District Medical Society,
Nipawin SK, Oct 9, 1991.
Lecture. “Update on Parkinson’s Disease in the Elderly”, Canadian Psychiatric
Association, Saskatoon SK, Oct 4, 1991.

January 6, 2011 57
Dr. Ali H. Rajput
Chairman. Current Management in Parkinson’s Disease, Saskatoon SK, Sept 9, 1991.
Lecture. “Movement Disorders”, Nurses Education Days, Medicine 6300, Aug 22 & 27,
1991.
Visiting Professor. Dow Medical College, Karachi, Pakistan, July 7, 1991.
Lecture. “An Update in Parkinson’s Disease”, Pakistan Neurological Society, July 6,
1991.
Visiting Professor. University of Western Ontario, May 15, 1990.
Toronto Neurology Update (University of Toronto). Etiology and Clinical Manifestations
of Parkinson’s Disease, May 4, 1990.
Etiology and Clinical Features on Parkinson’s Disease, Montreal General Hospital, May
1990.
Grand Rounds in Parkinson’s Disease:
Toronto – “Differential Diagnosis of Common Movement Disroders”, Mar 2, 1990
Montreal General Hospital, March 6, 1990
Clinical Scholar and Visiting Professor, Eli Lilly Laboratories, Indianapolis, Apr 4,
1989
Visiting Professor. Neuroepidemiology, Neurology Research Group Meeting, UBC
Health Centre, March 8, 1989.
Managing the Complications of Parkinson’s Disease. City Wide Neurology Rounds. St.
Paul’s Hospital, Vancouver BC, March 8, 1989.
Parkinson’s disease – Modern Management, Vancouver Medical Society, Mar 8, 1989.
Epidemiology of Parkinson’s Disease in Saskatchewan, Parkinson Research
Committee, San Jose CA, Oct 21, 1988.
Advisor. Summary and Observations of PERC Proceedings, San Jose CA, Oct 22,
1988.
Role of Voluntary Agencies in Parkinson’s Disease. The Parkinson Foundation of
Canada, Toronto, Sept 8, 1988.
Environmental Causative Factors for the Occurrence of Neurological Disorders in North
America. 41 st Annual Conference of Canadian Water Resources Assoc., June 24, 1988
(invited lecture and abstract).

January 6, 2011 58
Dr. Ali H. Rajput
Visiting Professor: McMaster University, Hamilton ON, Mar 23, 1988
University Hospital, London ON, March 25, 1988
University of Manitoba, Feb 1, 1988
Queen’s University (Kingston), May 21, 1987
University of Alberta (Edmonton), Nov 18, 1986
University of British Columbia Hospital, July 1986
University of Calgary, Oct 1985
Rutgers Medical School, New Brunswick, NJ, May 22, 1985
University of Manitoba, Jan 10-11, 1985
University of Alberta (Edmonton), March 30, 1984
Lecture. Current Management of Parkinson’s Disease. Toronto Chapter, Canadian
Parkinson’s Disease Foundation, Toronto ON, April 27, 1982.
Lecture. Management of Parkinson’s Disease and Evolution of Parkinson’s Foundation
in Saskatchewan. Ottawa-Carleton Parkinson’s Society, April 26, 1982.
Lecture. Parkinson’s Disease Foundation, Toronto ON, 1975
(During last 2 years approximately 10 lectures annually to CME, CNE, CPE)
XXI. RESEARCH GRANT INFORMATION
Current:
Parkinson Study Group (NIH) – POST-CEPT study
Allergan – MDs on BOTOX Utility
Parkinson Study Group – FOUND study
Parkinson Study Group - Molecular Biometrics – SPIN PD study
University of Rochester – PATCH study
University of Rochester – PROGENI study
Rhone Poulenc Rorer – Riluzole in P.D.
SmithKline Beecham – Ropinirole Study
University of Rochester – TEMPO study
Pharmacia & Upjohn – CALM –PD Study
Astra Pharma Inc – SA-CMZ-0009
Wake Forest University School of Medicine – VISP
Sask. Parkinson’s Disease Foundation – P.D. Clinic
Previous Research Grants:

January 6, 2011 59
Dr. Ali H. Rajput
Michael J Fox Foundation. Genetic Modulation of Clinical Course in
Pathologically Proven Parkinson’s Disease. R. Camicioli, A.H. Rajput, Alex Rajput,
C. Hau, H. Payami. 2001
Gain Americas – Glycine Antagonist in Neuroprotection
Glaxo Wellcome Inc – 20 mg sumatriptan nasal spray in the acute treatment of migraine
Pfizer Central Research – Migraine study (Eletriptan)
Bayer – Metrifonate Study
Boehringer Ingelheim – Pramipexole/Bromocriptine Study
Neurosciences Pharma – DHEA-02 Study
Pfizer – Aricept Study
University of Rochester – DARE study
Pharmacia & Upjohn – Pramipexole Study
Cromedica - Lazebemide in Alz. Dis.
Hoffman-La Roche – Tolcapone in P.D.
Upjohn/PSG/Besselar (Step-up)
Allergan - Study of Botulinum toxin in Essential Tremor
National Institute of Health USA - DATATOP
ROADS study - R019 for early Parkinson’s Disease
Hoechst HP749 study – early Alzheimer’s Disease
American Parkinson Disease Association - Drs D.B. Calne & A.H. Rajput – Title:
Investigations of a New Hypothesis on the Etiology of Idiopathic Parkinsonism,
1991.
Canadian National Study of Health and Aging (with C. D’Arcy)
University of Saskatchewan Fellowship Award (R4)(open competition)(for 2 years)
Sinemet CR Clinical Trials
The Parkinson Foundation of Canada, K.M. Semchuk, A. Senthilselvan, H.
McDuffie, A.H. Rajput – Title: Agricultural Occupational Expusure to Pesticides,
1991
The Parkinson Foundation of Canada for chemical composition of water
consumed in childhood and idiopathic Parkinson’s Disease.
Clinical Trials of: Prolopa in Parkinsonism
Propranolol in Essential Tremor, Drug, Ayerst
Sinemet in Parkinson’s Disease, Merck-Sharpe and Frosst
Symmetrel in Parkinson’s Disease
Tegretol in Epilepsy
L-Dopa in Parkinsonism
Current Research Interests:
Neuroepidemiology
Movement Disorders in General, Parkinson’s Disease, Essential Tremor and
Dystonia in Particular:
a) Etiology
b) Pathophysiology

January 6, 2011 60
Dr. Ali H. Rajput
c) Biochemistry (in conjunction with O. Hornykiewicz, P. Bedard, T. Dipaulo)
d) Clinical Pathological Correlates (with Dept of Pathology)
e) Drug Therapy
f) Prevention of Progression in Parkinson’s Disease.
Alzheimer’s Disease
Geriatrics – and Cause of Disability
Normal Aging
Genetic study of Progressive Supranuclear Palsy (PSP) with European PSP groups.
XXIII. PROFESSIONAL PRACTICE/CONTINUING MEDICAL EDUCATION
Grant Reviewer for Special Emphasis Panel – National Institute of Environmental
Health. Oct 27, 1999 and March 1-3, 2000.
Participated with member of the Consensus Meeting in special conference on Levodopa
in Parkinson’s disease: Where do we stand? Paris, France, Jan 7, 1998
Review of 1996 Nomination Evaluation for Manning Awards for Dr. S. Weiss, Alberta
External Advisor, Dept of Psychiatry Organizational Project.
American Academy of Neurology Course, May 9, 1992. “Controversies and Consensus
in Neurology”. The Environmental Causation of Parkinson’s Disease.
Ad hoc reviewer for journals and granting agencies:
A) Journals - 1) Neurology
2) Canadian Medical Association
3) Neuroepidemiology
4) Movement Disorders
5) Canadian Journal of Neurological Sciences
6) Annals of Neurology
7) Archives of Neurology
8) Neurogenerative Disorders
9) New Sask. Journal of Medicine
10) Abstract reviewer for American Academy of Neurology (Annual
Meeting)
11) Abstract reviewer for Movement Disorder Society (International)
(Annual meeting)
Ad hoc reviewer of papers for journals:
1) Canadian Journal of Neurosciences
2) Neurology
3) Parkinsonism & Related Disorders

4) Neuroepidemiology
5) Annals of Neurology
6) Movement Disorders
7) Journal of Neurology, Neurosurgery, and Psychiatry
January 6, 2011 61
Dr. Ali H. Rajput
B) Grant Reviewer for:
1) Parkinson Foundation of Canada
2) United Parkinson Foundation, USA
3) National Institute of Health, USA
4) Medical Research Council of Canada
5) Univ. of Kansas Alzheimer’s Disease Centre (NIH), May 13, 1994
C) Editor for:
XXIV. CONSULTING WORK
1) International Abstracts (quarterly) – Parkinson’s Disease 1993
2) (Regional Editor) Neuroepidemiology
Ad Hoc Consultant. Applicant Interviews. University of Rochester Medical Centre. NIH
1995-96
Lerman Consulting Management of Parkinson’s Disease. Four teleconferences – Oct
18, 30, Nov 1 (2), 1995.
Consultant (NIH) Alzheimer’s Disease Epidemiology Study. Kansas City KS, Jan 29,
1993
Consultant Parkinson’s Disease (NIH) Epidemiology Study. Kansas City KS, Jan 27-28,
1993
Consultant to Burroughs Welcome Company on Sudden death in seizure disorders in
Saskatchewan 1990.
Consultant to W. Koller et al. – (Epidemiological study of Alzheimer’s disease in Kansas
funded by NIH), 1991.
Advisor, National Institute of Aging (NIA-NIH), USA, on Essential Tremor in the Aging
Nervous System, 1990
Consultant to National Institute of Aging (NIH), USA on tremor symposium, 1990
Scientific advisor on Studies of Parkinson’s Disease and Alzheimer’s Disease. (Marion
Merrell Dow).
Canadian consultant to PATH (C.M.E. in Parkinson’s Disease), 1990-92.

January 6, 2011 62
Dr. Ali H. Rajput
Honorary consultant, Saskatchewan Occupational Therapy Society 1977-83
XXV. DEPARTMENTAL AND COLLEGE COMMITTEES
Tenure Committee, Department of Medical Imaging. October 1996.
Internal Survey Committee. Division of Orthopedic Surgery, Dec 1995.
Member, Dept of Medicine CPP Finance Committee.
Member, Epidemiology Research Group, College of Medicine.
Member, Executive of Faculty, College of Medicine. 1990-.
Member, Medical Advisory Committee, University Hospital, 1986-1987.
Ad Hoc member, Tenure and Promotion Committee, Department of Psychiatry.
Member, Promotions Tenure Committee, Department of Medicine
Member, College of Medicine Library Committee for six years.
Member, Postgraduate Education Committee.
XXVI. UNIVERSITY COMMITTEES
Phase 5 Sub-Committee, Undergraduate Education Committee
Promotion Committee. Department of Community Health & Epidemiology Oct 1994.
Search Committee for Head, Department of Rehabilitation Medicine, December 1994.
Member, University Review Committee, 1993-1996.
Meet with the Health Sciences Deans, U of S. re: Funding Problems. Apr 19, 1994.
University of Saskatchewan Public Relations Focus Group ,1.5 hr session, May 13/94.
Reviewer, Site visit for MRC program grant application of Dr. K. Midha, et al, College of
Pharmacy.
Member, University of Saskatchewan (U of S) Committee for Review of the President.
Ad hoc Internal Reviewer for Neurosurgery Residency Program, U of S.
Member, Competence Evaluating Committee, Postgraduate Education, U of S.
Member, U of S Committee on Scholarships and Awards, 1990-
Member, College of Postgraduate and Research, U of S, 1991-
Member, Coordinating Committee of Council, U of S, 1991-
Member, Whelan Lecture Steering committee, U of S, 1991-.
Director, Movement Disorder Interest Group at U of S, 1992-.
Founder, Movement Disorder Interest Group at U of S, 1992.
Representative, U of S Faculty Association, 1986-88.
Member, U of S Faculty Association Grievance Committee, 1990-92.
XXVII. PROFESSIONAL & ASSOCIATION OFFICES AND COMMITTEE
ACTIVITY OUTSIDE UNIVERSITY

January 6, 2011 63
Dr. Ali H. Rajput
Member, Research Committee on Parkinsonism and Related Disorders. World
Federation of Neurology. June 1999.
Member, W.H.O. (World Health Organization) Working group on Parkinson’s disease.
Chair, Professional standards and ethics Committee for the Cooperative Ataxia Group
1999.
Canadian Team Doctor. Saskatchewan Amateur Boxing Assn. 1998.
Appointed member World Health Organization Working Group in Parkinson’s Disease
1997.
Member, Scientific Advisory Board (4 yr) American Parkinson Disease Assn, Inc. Oct
1995.
Member, 1996 Examination Board. Royal College of Physicians & Surgeons of
Canada.
Examiner, Royal College of Physicians & Surgeons of Canada. Written Sept 1995 and
Oral exam Nov 1995.
Member, Scientific Advisory Committee. Canadian Parkinson Foundation 1996-.
Member, Scientific Advisory Committee, Dystonia Foundation, 1994-.
Member, American Association for the Advancement of Science.
Editorial Board, “Parkinsonism and Related Disorders” journal.
Member, Business & Professional Campaign. Heart & Stroke Foundation of
Saskatchewan
Member, External Advisory Board, Alzheimer’s Disease Centre, University of Kansas.
Site visit May 5, 1995.
External referee MRC grant, Dr. D.B. Calne, et al, U.B.C.
Roundtable discussion, Tolcapone, Hoffmann-laRoche. May 9, 1995.
Dystonia Foundation grant review. Site visit, New Orleans, Feb 3-4/95 (5 working days)
Examiner specialty. Royal College of Physicians & Surgeons of Canada. Theory
papers-essay questions Sept/94, Oral exam Nov 1994 (total 8 working days).
Member, Provincial Health Council, 1993-1996.
Member, Representative Assembly (Neurology Representative) Saskatchewan Medical
Association, 1991-
Representative (elected) Saskatoon District Association of Physicians & Dentists.
Member, Professional Advisory Board, Learning Disabilities Assoc of Saskatchewan
1990-95.
Member, Medical Advisory Committee, Saskatchewan Heart & Stroke Foundation,
1990-.
Member, Profession and Education Committee, Saskatchewan Heart & Stroke
Foundation for 2 years.
Member, Consortium of Canadian Centres for Clinical Cognitive Research 1993-.
Member, Editorial Advisory Board. The Medicine Group 1993-.
Moderator and Presenter. Levodopa therapy Then & Now, Parkinson’s disease
problems & case discussion. Saskatoon, April 19/93.
Member, National Defence Environmental Advisory Committee, 1993-95.
Examiner. Royal College of Physicians & Surgeons of Canada (Neurology) 1992
Grant Reviewer and site visitor for MRC major grant for PET scanning at Univ of B.C.

January 6, 2011 64
Dr. Ali H. Rajput
Epidemiology of Parkinson’s Disease at Canadian Advisory committee on Deprenyl.
Mar 2/91.
Chaired, Teleconference on Parkinson’s disease. Sandoz Canada, Jan 8/91.
Chaired, Teleconference, Jan 8/91 re: symposium on Parkinson’s disease in Apr 1991.
Organized and chaired half day course in Movement Disorders for Canadian
Neurological Society, 1991.
Chairman, Deprenyl Advisory Group, 1989-91.
Chief organizer, session chairman, moderator for National Conference on Parkinson’s
disease, Victoria, B.C., 1990.
Member, Scientific Advisory Board, Dystonia Medical Research Foundation, 1994-98.
Member, External Advisory Committee on Alzheimer’s Disease Centre Core Grant (NIH
funded) Univ of Kansas, 1994.
Member, Editorial Board, Journal Neuroepidemiology.
Member, Editorial Board, Movement Disorders journal.
Member, National Institute of Health, USA Scientific Review Committee for C. Tanner,
et al ($3 million dollar grant application) – 1992 (by invitation).
Chairman, Neurogenetics Session on Parkinson’s Disease at American Academy of
Neurology Annual Meeting, 1991.
Organized and chaired one-half day course in Movement Disorders for Canadian
Neurological Society, Halifax, June 19, 1991.
Chairman, Epidemiology and Etiology of Parkinson’s Disease at 3 rd Canadian
Conference on Neurogenerative Disease – Parkinsonism. L’Estrel, Quebec, Apr 5/91.
Chairman, Clinicopathological correlative studies in Parkinson’s Disease of Parkinson
Study Group, 1991
Member, Parkinsonism Epidemiology Research Committee on Diagnostic Criteria of
Parkinson’s Disease, 1991.
Member, Medical Advisory Committee, International Tremor Foundation, 1990-.
Member, International Tremor Foundation Diagnostic Criteria and Classification Group
1990-.
Member, Neurology of Aging, Division of American Academy of Neurology, 1990-.
Chairman, International Tremor Foundation Pathological Studies Committee, 1990-.
Epidemiology & Etiology of Parkinson’s Disease. A Roundtable Discussion on Current
and Future Trends in Treatment and Quality of Life, by MES Med Education Services,
1988.
Summary of Current Status of Epidemiology of Parkinson’s disease. Special Session on
Parkinson’s disease, Quebec City, Jun 18, 1988.
Organized and chaired symposium on Transplantation in Parkinson’s disease, Quebec
City, Jun 18, 1988.
Summary and Observations of PERC proceedings (Advisor), San Jose, California, Oct
22, 1988.
Founder, Movement Disorder Group of Canada
Organized first symposium on Movement Disorder in Canada, May 1987, Ottawa.
Secretary, Movement Disorder Group of Canada for 2 years.
President, Movement Disorder Group of Canada for 2 years.
New epidemiological Approach to Parkinson’s Disease. Movement Disorder group of

January 6, 2011 65
Dr. Ali H. Rajput
Canada symposium, May 22/97, Ottawa.
Computer simulation of Parkinson’s disease. Ed. Donald Calne, Knowledge House,
Halifax.
Combination Therapy for Parkinson’s Disease, Case Study #3, Sandoz Canada.
Member, Scientific Advisory Committee, Deprenyl research, 1989-.
Member, Executive of Canadian Neurological Society for 2 years.
Scientific advisor to Canadian Huntington’s Society for 2 years.
Member (Ethics Committee) DATATOP (NIH USA funded $10 million Study), 1989-.
Member, DATATOP Clinical Correlation Committee.
Member, DATATOP Study of Parkinson’s disease 1986-.
Member, World Federation of Neurology, Neuroepidemiology Group, 1988-.
Member, World Federation of Neurology , Neuroepidemiology Group, 1988-.
Member, World Federation of Neurology, Research in Extrapyramidal Disorder, 1986-.
Member, Parkinson’s Study Group (International), 1986-.
External referee for Promotion to professor rank for 1) Columbia University, New York,
2) University of Rochester, Rochester, New York
External referee for promotion to associate professor rank for Robert Wood medical
College, New Jersey.
Member, Medical Advisory Committee, Allergan (International).
Member, Geriatric Neurology Research group of the American Academy of Neurology
1990-.
(Active) MEMBERSHIP, PROFESSIONAL ORGANIZATIONS
Saskatchewan Medical Association
Royal College of Physicians and Surgeons of Canada
Saskatchewan College of Physicians and Surgeons.
Canadian Neurological Society
Canadian Movement Disorder Group
American Electroencephalographic Society
American Academy of Neurology (Fellow)
American Neurological Association (Elected)
Canadian Society of Clinical Investigation
World Federation of Neurology Research Group
Canadian Medical Association.
XIX. PUBLIC & COMMUNITY CONTRIBUTIONS – NON-UNIVERSITY
American Neurological Association Press Interview – October 1, 2001. Based on
increased concentration of a novol compound ADTIQ in Parkinson Brains.
June 16/99. Interview Mike Iskedjian of Smith Kline Beecham regarding dyskinesias in
Parkinson’s disease.
Dec 1/98. Interview with radio station CKOM with Mike Gormley on Parkinson’s

January 6, 2011 66
Dr. Ali H. Rajput
Disease regarding Michael J Fox.
Nov 27/98. Interview for McLeans magazine regarding an article on the cause of
Parkinson’s disease.
Invited speaker. DYT 1 gene marker for Saskatoon (North) Dystonia Assoc. Mar 8/98.
Nov 7/96. Talk on Parkinson’s Disease. Support Group, Saskatchewan Parkinson’s
Disease Foundation.
Dec 4/96. Interview John Lewis of Who’s Who.
Apr 30/96. Interview on Alzheimer’s disease. Linda Boutin
June 1/96. Update on Parkinson’s disease. Annual General meeting of Saskatchewan
Parkinson’s Disease Foundation.
Mar 20/96. Presentation Knox United Church, “Healing the World”.
Apr 24/96. CFQC-TV “Community Line” interview on Parkinson’s Disease.
T.V. interview, 15 min, CBC Susan Adaskin
Apr 7/95. CFQC-TV interview, Kristy Snell. Alzheimer’s disease relationship to
aluminium in our water.
Apr 6/95. Telephone interview, Castelli Assoc. Pramipexole experience.
Apr 4/94. Telephone interview, Linda Smith, freelance reporter from Albuquerque N.M.
on “Informed Consent”.
Apr 13/94. M. Nundy & L. Boison, Bishop Mahoney High School students. A morning
exposure to Neurology.
Mar 2/94. Telephone Interview (15 min) Bill Doskoch, Regina Leader Post, Regina, SK.
Dec 4/93. Personal Interview (1.5 hr) Dr. Marilynn Cooper, Medical Director,
Citizenship & Immigration International Service. Ottawa, ON. Impact of Neurological
Disease in Immigration Canadian Health Care system.
Apr 1984. Invited by American Academy of Neurology at Annual General Meeting for a
press interview, re: Etiology of Parkinson’s Disease, Environmental Factor(s).
Apr 1983. Invited by American Academy of Neurology for a press interview, re: Long
term Efficacy of Low Dose Levodopa in Parkinson’s Disease.
Co-Founder, Saskatchewan Parkinson’s Disease Foundation.
Played major role in founding of Kinsmen Foundation for the Handicapped (Telemiracle
Saskatchewan).
Published four editions of brochure on Parkinson’s disease for Saskatchewan
Parkinson’s Disease Foundation.
Helped organize Ottawa-Carleton Parkinson Society.
Helped organize Parkinson Foundation of British Columbia.
Prepared public service television message on Parkinson’s disease in Saskatchewan
1974
Served on the Board of Friendship Inn.
Secretary, Saskatchewan Parkinson’s Disease Foundation 1973-.
Member, Board of Directors, Parkinson Foundation of Canada 1987-90.
May 17/93. Telephone interview by Bev Hastingson, Assoc Editor, Medifacts Healthcare
Communications on Parlodel.
Apr 20/93. Featured researcher, Medical Research Day, Saskatoon SK.
Spring 1993. Interview, U of S, Green & White.
Feb 19/93. T.V. Interview for STV on Alzheimer’s Disease Research, Saskatoon.
Jan 25/93. Telephone interview (30 min). Harriet Washington (reporter) Harvard School

January 6, 2011 67
Dr. Ali H. Rajput
of Public Health. Reporting on Parkinson’s Disease.
Jan 21/93. CBC French Radio (Regina). 20 min interview.
New Conference, U of S. Parkinson Study Group. Participating media: Radio: CFQC,
CKOM; TV: CFSK, CKCK.
Jan 21/93. New release. Star Phoenix. Parkinson’s Progression Delayed by Drug,
Scientist Claim.
Jan 21/93. Press interview on DATATOP Study, Saskatoon SK, published NEJM.
Jan 25/93. Telephone interview Deprenyl vice-president, Roger Odette. Protective &
Symptomatic effect of Deprenyl.
Jan 20/93. CFQC Radio Interview (10 min).
Jan 12/92. CBC Television, M. Linden for Cause of Parkinson’s Disease.
Nov 30/92. F. Thompson, M.L.A. Athabasca, on Transplant for Parkinson’s Disease.
Oct 1992. Interview in Medical Research Foundation’s Householder/mailer.
Aug 14/92. Norman Oliver, Member of Neurology Editorial Staff. 20 min interview on
Current Survival in Parkinson’s Disease.
July 14/92 Andrea Emard, Chatelaine Magazine. Telephone interview on Parkinson’s
disease treatment and the reasons why I am studying Parkinson’s disease.
(Have been interviewed frequently by different media including “As it Happens” on CBC.
Was invited to appear on CBC Journal but was out of country at that time.)
(Gives approximately 10 – 15 public lectures, television, radio and newspaper interview
annually.)